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ABSTRACT 
 
 A novel method for the dearomative reduction of arenes through the use of N,N-arenophile, 
MTAD, was developed. Cheap feedstock arenes undergo photocycloaddition with MTAD, and the 
cycloadduct can be treated further to furnish novel 1,3-cyclohexadienes or 1,4-diamino-2-
cyclohexenes. The utility of this method is shown in the synthesis of a natural product in two steps 
from naphthalene.  
  
 Calotropin, a cardiotonic steroid, isolated from Apocynaceae plants is a highly cytotoxic 
natural product with anti-cancer activity. A total synthesis strategy which utilizes a NHC-catalyzed 
benzoin condensation, and Pd-catalyzed nucleophilic dearomatization of a phenol is described. 
Also described, is the semisynthetic strategy towards calotropin from estrone, where the aromatic 
A ring is dearomatized to introduce a C1 fragment at the para-position.    
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CHAPTER 1: DEAROMATIVE REDUCTION OF ARENES THROUGH THE USE OF 
ARENOPHILES 
 
1.1. INTRODUCTION 
 
Aromatic compounds such as benzene, toluene, and naphthalene are inexpensive, 
feedstock chemicals. These arenes can be converted into highly reactive dienes, and further 
manipulated to generate compounds of high molecular complexity. Examples of dearomatization 
reactions include: the Birch reduction, oxidative dearomatization of phenols, microbial arene 
oxidation, and stoichiometric transition metal-mediated transformations of arenes.1,2 Such 
reactions are extremely powerful synthetic tools that have been used on industrial scales to 
synthesize pharmaceutical compounds; however, these methods are limited- in both the 
functionality that can be incorporated during the dearomatization step and the scope of compatible 
substrates. 
Our research group has developed a novel approach for the dearomatization of arenes, 
which is based upon the para-photocycloaddition of an arenophile, 4-methyl-1,2,4-triazole-3,5-
dione (MTAD) 1, with an arene under visible light, to afford a cycloadduct 2 with two isolated 
olefins (Figure 1). 3 This cycloadduct can then undergo diimide reduction4 on the less substituted 
olefin, furnishing reduced cycloadduct 3 which can be further manipulated to give cycloreverted 
product, cyclohexadiene 4, or N-N bond cleaved product, diaminocyclohexene 5.5 
Figure 1. Reductive dearomatization of arenes with N-N arenophile, MTAD. 
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1.2. CYCLOADDITION 
 
 It was found that running the cycloaddition at -78 °C in EtOAc under visible light 
irradiation until the pink colour disappeared was optimal. The disappearance of the vibrant pink 
was an indication of the consumption of MTAD in the cycloaddition, and further chemistry was 
to be initiated. The diimide reduction was run at -50 °C for 5 h in the presence of acetic acid. 
Lower temperatures resulted in lower yields, likely because the diimide was not being generated. 
 When the optimized 
conditions for the diimide 
reduction of MTAD 
cycloadducts was determined, 
the scope of the cycloaddition 
was explored (Figure 2). A 
mixture of unseparable 
constitutional isomers were 
isolated and characterized, with 
the reduction of the less-
substituted olefin product usually 
being the majority. The 
transformation was tolerant of 
many substrates containing: 
alkyl (7, 8, 23, 25, 27), halo (9, 
19, 21, 24), silyl (10), ester (11, 
13, 14, 20, 22), protected nitrogen (12), ketal (16, 17, 18) functional groups. Of note, biaryl product 
Figure 2. Substrate scope for cycloaddition for mononuclear 
arenes. 
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22 resulted in a 2:1 mixture of constitutional isomers across the 3,6-position of the more substituted 
arene.  
An unexpected product isolated was 26, where MTAD added across the pyridine ring, 
rather than the phenyl ring. Addition across the phenyl ring 
was not observed at all. Other pyridyl substrates were 
tested (Figure 3), but no cycloaddition was observed. It 
was expected that 3-phenylpyridine and 4-phenylpyridine would not give any product since 
cycloaddition across the 2,5-positions give trisubstituted olefins, which are difficult for diimide 
reduction. Disubstituted arenes gave very low yields (27) or no cycloaddition occurred at all in the 
case of o-,m-, and p-xylenes.  
Cycloaddition of 
polynuclear arenes and 
heteroarenes proceeded in 
higher yields and shorter 
reaction times, due to the lower 
resonance stabilization energy 
per ring of these molecules 
(Figure 4). Cycloaddition across 
2-phenylnaphthalene occurred 
selectively on the naphthalene 
ring, further away from the 
phenyl substituent. Nitrogen-
containing heteroarenes: 
Figure 3. Pyridines tested. 
Figure 4. Substrate scope for cycloaddition of polynuclear 
arenes. 
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quinoline (33), quinoxaline (34), acridine (35), and benzoquinoline (36), underwent cycloaddition 
in high yields. Dearomatizations of mononuclear and polynuclear substrates were very efficient 
and could be scaled up to a gram or more of MTAD (11, 28). 
 
1.3. CYCLOREVERSION 
 
In order to cyclorevert the reduced cycloadducts to cyclohexadienes, the urazole moiety 
must be removed, and the resulting cyclic hydrazine oxidized to diazo compound, for the 
retro[4+2] to occur (Figure 5).  
 
 
 
 Hydrazine (monohydrate and anhydrous) was not a good base for the removal of the 
urazole. Residual hydrazine could not be removed, and interfered with the oxidation step with 
copper. Hydroxide bases were found to be the best base for this step. Hydroxide bases, KOH and 
NaOH, in protic solvents, MeOH and iPrOH, were tested at 60 °C, 80 °C, and 100 °C. It was found 
that higher temperatures lead to higher yields. KOH was a better base than NaOH. Methanol gave 
slightly higher yields than isopropanol; however, there were concerns about heating methanol to 
100 °C, so isopropanol was the solvent of choice for the cycloreversion. After neutralization of 
base with acetic acid, addition of aqueous CuCl2 oxidized the hydrazine immediately and the 
discontinuation of gas evolution was a sign of completion of cycloreversion. With optimized 
conditions in hand, the cycloadducts that could undergo cycloreversion were looked at (Figure 6). 
Alkyl (37, 38), silyl (39,40), and ketal (45, 46, 47) containing substrates were well tolerated. Esters 
were deprotected under basic conditions to reveal alcohols (41, 43, 44) or acids (49, 51). Primary 
amine 42 was unveiled from the bis-Boc protected cycloadduct 12. iPropyl ether 48 was derived 
Figure 5. Cycloreversion of reduced cycloadducts to cyclohexadienes. 
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from the corresponding bromide cycloadduct 19. The only substrate containing a halide was 50, 
since it was tertiary. Cycloadducts 8 and 9 and other primary and secondary halides gave an 
uncharacterized mixture of elimination and products.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.4. N-N BOND CLEAVAGE 
 
 Fragmentation of the N-N bond for polynuclear substrates proceeded through the removal 
of triazolinedione moiety with hydrazine, followed by heterogeneous catalytic reduction of the N-
N bond with Raney Nickel®.6 Hydrogen was generated in situ, through catalytic degradation of 
hydrazine to hydrogen and nitrogen gas. Many polynuclear arenes and nitrogen-containing 
heterocycles were compatible with this method (Figure 7). Of note, pyridyl bromide 55 was 
tolerated. Protodehalogenation was seen with substrates based on naphthalene (61, 62) during 
Figure 6. Substrate scope for cycloreversion. 
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catalytic reduction, yielding 52, so it was surprising the see it survive with the quinoline substrate, 
which is more electron-deficient and should facilitate oxidative addition of the nickel catalyst.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.5. SYNTHETIC APPLICATIONS 
 
 The utility of the dearomative reduction of arenes was showcased in the synthesis of 
bioactive marine natural product 63 (Figure 9).7 In two steps from feedstock chemical, 
naphthalene, a compound of much greater value was synthesized. After isolation of the reduced 
cycloadduct, exposure to hydrazine gave the cyclic hydrazine substrate, which under oxidative and 
basic conditions, gave the Kornblum DeLaMare product 63. 
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CHAPTER 2: STUDIES TOWARDS THE SYNTHESIS OF CARDIOTONIC STEROIDS 
CALOTROPIN AND CALACTIN 
 
2.1. INTRODUCTION 
 
 Calotropin 64 and calactin 65 (Figure 10) are 
cardenolide steroids isolated from the milkweed of many 
genera of the Apocynaceae family, found in Africa, Asia, 
Europe, Australia, South America, and tropics of North 
America.8 The first historical use of the milkweed was in 
African dart arrow poison, for their cardiac arresting 
properties, leading to death.9 Calotropin is very active against 
multiple cancer cell lines, with IC50 values in the 1-2 nM range. Its cytotoxicity has been attributed 
to caspase activation and down-regulation of apoptotic proteins in the Wnt signaling pathway.10 
Their potent biological activities make calotropin and calactin attractive targets for total synthesis. 
The crystal structure of calactin has been obtained.11  
 The structures of calotropin and calactin differ in the configuration of the stereocentre of 
the hydroxyl group off the sugar portion of the molecule. The dideoxypyran sugar portion of the 
molecule is connected to the steroid core through the dioxane ring, in a cis, cisoid, trans-fusion 
(Figure 11).  
 
 
 
 
  
 
 
 
Figure 10. Structures of calotropin and 
calactin. 
Figure 11. Connectivity of glycon portion to 
steroid. 
Figure 12. Structual features of 
calotropin and calactin. 
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 The structures of the steroid cores of the molecule are unique to the cardenolide class, 
where a cis-CD ring fusion exists, rather than the standard thermodynamic trans-fusion (Figure 
12). Two other notable features of the molecules are the C19 aldehyde, and C17 butenolide, both 
sensitive functionalities that should only be revealed towards the end of a synthesis. 
 
2.2. SYNTHESIS OF OTHER CD-cis FUSED STEROIDS 
 
 Although calotropin and calactin have never been synthesized before, other CD-cis-fused 
steroids have been the targets of synthetic campaigns. Oubagenin 66, has been synthesized 
semisynthetically and twice by total syntheses. The Deslongchamps’ group was the first to 
synthesize oubagenin, using a polyanionic cascade to build the B and C in a total of 27 steps from 
their advanced intermediates (Figure 13).12 Although oubagenin has many different features than 
calotropin, some of the strategies in appendment of the butenolide or installation of similar 
stereocentres can lend themselves to the synthesis of calotropin. 
 
 
 
 
 
 
 
 
 
 
 
 
The Baran group synthesized oubagenin through a semisynthetic approach. They started 
with adrenosterone, and use the existing functional handles to direct in a site- and stereospecific, 
C-H oxidations at other positions, in what they termed a redox-relay approach (Figure 14).13  
Figure 13. Deslongchamps total synthesis of oubagenin. 
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The most recent and shortest synthesis is from the Inoue group, albeit their starting 
materials were very advanced and took 15 steps to make from commercially available starting 
materials (Figure 15).14 They made use of a radical conjugate addition of 67 into enone 68, with 
the resulting enolate displacing the acetoxy group to close the C ring of the steroid.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 Last year, the Nagorny group synthesized multiple steroids containing CD-cis-fused rings, 
in a highly convergent, efficient, and stereocontrolled manner (Figure 16).15 In 7 steps, from 
commercially available starting materials, they build a steroid core which is common to many 
natural products. This common intermediate is then highly diversifiable, and allows them to reach 
several targets, shown below. In fact, this strategy could also potentially be used to build 
calotropin. 
 
 Figure 14. Baran's semisynthesis of oubagenin. 
Figure 15. Inoue's synthesis of oubagenin. 
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2.3. RETROSYNTHETIC ANALYSIS 
 
The focus of the retrosynthetic planning was the development of a steroid core synthesis 
that was original and highly convergent. The retrosynthetic analysis of calotropin 64, outlined in 
Figure 17, begins with the disconnection of the glycon portion of the molecule, giving rise to the 
glycosylating reagent 69, which is available in 7 steps from glucose, and C2,C3-trans-diol steroid 
70.16 The trans-diol can be elaborated from dienone 71, and installation of a butenolide on the D 
ring at C17.12-15,17 The dienone was envisioned to be a product of an asymmetric intramolecular 
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palladium-catalyzed nucleophilic dearomatization of a phenol by the aryl bromide fragment 72.18 
The dearomatization occurs through oxidative addition of the palladium catalyst into the vinyl-
bromide or aryl-bromide bond, followed by nucleophilic attack of the para-position of the phenol 
upon the Pd(II) centre (Figure 18).19 Subsequent reductive elimination of the cyclohexadienone 
and arene yield the dearomatized product and regenerates the catalyst. This transformation was 
previously utilized in the synthesis of triptoquinone H and its epimer by the same group that 
developed the methodology. Disconnection of the phenol and vinyl bromide gives rise to styrene 
74 and bicyclic dione 73. The latter may be traced back to linear aldehyde precursor 75 through 
an asymmetric NHC-catalyzed benzoin condensation.20    
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Figure 17. Retrosynthetic analysis of calotropin. 
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Figure 18. Asymmetric Pd-catalyzed phenol dearomatization in synthesis of triptoquinone H. 
 
2.4. APPROACHES TOWARDS THE CD RINGS 
 
 The first goal of the project was amassing large quantities of dione 73, to try multiple routes 
to the steroid core. Known strategies to synthesize linear precursor 75, involve alkylation of 2-
methyl-1,3-cyclopentadione (76) with an activated C4-electrophile, followed by functional group 
interconversions. The equilibrium state of 2-methyl-1,3-cyclopentadione is primarily the β-
hydroxyenone (Figure 19), therefore O-alkylation predominates over C-alkylation unless an 
activated electrophile or Michael acceptor is used. 
 
 
 
The published procedure to the linear precursor to benzoin condensation intermediate 75, 
was followed; however, there were difficulties in the purification of synthetic intermediates 
(Figure 20).21 The route commenced with the radical bromination of methyl crotonate 77 to yield 
allylic bromide 78, which was purified through distillation. Reduction of the methyl ester to the 
allylic alcohol 79 with DIBAL appeared to give clean conversion by TLC and with some impurities 
Figure 19. Tautomeric forms of 2-methyl-1,3-cyclopentadione. 
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by crude NMR. Attempts to purify allylic alcohol by column chromatography resulted in complete 
degradation of the product, presumably by polymerization of the allylic bromide.  
  
 
 
 
 
 
 
 Attempts to carry the crude allylic alcohol forward by protecting the allylic alcohol with 
THP and TBS protecting groups were not fruitful (Figure 21). The same problem with column 
chromatography as in the case with the unprotected allylic alcohol was encountered.  
 
 
 
 
 
 
 Michael addition of 2-methyl-1,3-cyclopentadione into acrolein to yield aldehyde 79 is a 
well-known, high-yielding process (Figure 22). Aldehyde 79 has been shown to undergo Wittig 
olefination, so it was hypothesized that aldehyde 79 could be homologated using a 
methoxymethylphosphonium halide 80.15 A screening of bases yielded no desired product 81; only 
cross aldol products were detected.   
 
 
Me
O
OMe
NBS,
AIBN (cat.),
CCl4, O
OMe
Br
DIBAL,
THF, -78°C
OH
Br
77%
77 78 79
Figure 20. Attempted synthesis of allylic bromide 79. 
Figure 21. Synthesis of protected allylic alcohol 78-PG. 
Figure 22. Attempted homologation of aldehyde 79 using Wittig olefination. 
15 
 
An in situ hydrolysis of methyl vinyl ether 81 from Wittig oleftination also gave no desired 
aldehyde 82 (Figure 23). 
 
 
 
 
 The Horner-Wittig variant of the Wittig olefination, utilizing a phosphate olefinating 
reagent, was attempted, but no β-hydroxyphosphate 83 was detected (Figure 24). In situ 
elimination of the oxaphosphetane with base did not yield the desired vinyl methyl ether 81 (Figure 
25). 
 
 
 
 
 
 
 
 Attempts to homologate aldehyde 79 were abandoned for the original strategy of alkylation 
of cyclopentadione 76 with an activated electrophile, but a different route to the alkylating reagent 
was pursued. Beginning with THP protection of propargyl alcohol 84 to deliver terminal acetylene 
O
O Me
O
O
O Me O
ClPh3P OMe
nBuLi, THF;
then HCl
8279
80
Figure 23. Wittig olefination and in situ hydrolysis of aldehyde 79. 
Figure 24. Horner-Wittig addition into aldehyde 79. 
Figure 25. Horner-Wittig olefination of aldehyde 79. 
Figure 26. Synthesis of monoprotected butenediol 87 from propargyl alcohol. 
16 
 
85, the alkyne was deprotonated with nBuLi and quenched with paraformaldehyde in a Favorskii 
reaction to afford the monoprotected diol 86 (Figure 26). A Lindlar reduction of alkyne 86 in a 
variety of solvents, with careful monitoring by crude NMR of aliquots showed complete 
conversion to the allylic alcohol 87. Although this route was high-yielding, scalable, and quick, it 
was abandoned due to the commercial availability of cis-butene-1,4-diol 88. 
 The final approach taken to synthesize aldehyde 75 is shown in Figure 27. The viability 
and scalability of each step was determined for a series of protecting groups: THP, TBS, and Bn.   
 Due to the acid-lability of the THP group, analysis of reactions by TLC proved to be 
difficult. Despite this problem, milligram quantities of aldehyde 75 could be obtained by the end 
of the sequence. The alkylation step, deprotonation of the cyclopentadione 76 with NaH in DMF, 
followed by dropwise addition of the allylic bromide, was not scalable. At test scales, a moderate 
yield of 60% could be obtained, but scales above 300 mg resulted in 0 to 30% yield of desired 
product. O-alkylation product accounted for most of the mass recovery, but as scales went above 
1 g, most of the mass was not recovered. 
 Use of the TBS protecting group in the synthesis did not come with the same TLC analysis 
problems as the THP group, but the early bromination step was rate-limiting. Multiple conditions 
Figure 27. General route to aldehyde 75. 
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were tried: mesylation followed by bromination with LiBr in DMF, bromination with PBr3, and 
an Appel reaction. The Appel reaction was quantitative on small scales, but when the scale was 
increased, an uncharacterized byproduct which co-eluted with the desired product was formed. 
When this mixture of products was exposed to alkylation conditions, minimal alkylation product 
was detected.  
 The benzyl protecting group proved to be the most efficient of the protecting groups based 
on overall yield, scalability, and the combination of hydrogenation and deprotection steps (Figure 
28). The monoprotection of diol 88 proceeded with NaH in THF followed by treatment with BnBr 
in a 90% on a 20 g scale. Allylic bromide 90 was then prepared from alcohol 89 under Appel 
conditions on a 18 g scale in 77% yield. This was used as the alkylation agent in the presence of 
NaH in DMF with cyclopentadione 76. On a 2 g scale, the reaction went to completion, with a 
yield of 37%, but on a 3 g scale, with higher equivalents of base, there was incomplete consumption 
of cyclopentadione, and as a result, a lower yield of 23%. Parallel hydrogenation and 
Figure 28. Synthesis of aldehyde 75 using benzyl protecting group. 
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hydrogenolysis of the benzyl group with Pd/C under a H2 atmosphere provided the primary alcohol 
92, which was then oxidized under Parikh-Doering conditions to give aldehyde 75.  
 With aldehyde 75 in hand, the aldehyde–ketone, intramolecular benzoin condensation was 
attempted, the mechanism of which is shown in Figure 29. Deprotonation of the NHC salt 
generates the active carbene catalyst, which adds into the aldehyde. The Breslow intermediate is 
formed by tautomerization, and the resulting enamine attacks into the ketone which is an overall 
umpolung addition of aldehyde into the ketone. Elimination of the NHC catalyst to generate the 
product ketone and carbene catalyst completes the cycle.  
 The benzoin condensation was attempted with a variety of reported conditions with bases 
Et3N, Cs2CO3, and DBU, solvents THF, tBuOH, 
and EtOH, and at 60 °C.22 Commercially available 
thiazolium catalysts 93 and 94 were shown to 
catalyze the intramolecular benzoin condensation 
on similar substrates, so it seemed likely it would 
work on aldehyde 75, but no desired product was 
detected. The reported achiral and chiral 
triazolium catalysts 95 and 96 were difficult to 
obtain due to the required high quality Meerwein’s 
salt to synthesize them. 23 The total synthesis route 
stopped at this point in favour of the semi-
synthesis reported in Chapter 2.5. 
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2.5. SEMI-SYNTHESIS 
 
 An alternative to a novel synthesis of the steroid core was the semi-synthesis from a 
commercially available steroid. With most of the carbon skeleton in place, the synthesis would 
focus on chemo- and stereoselective oxidations. An attractive candidate to begin the synthesis was 
the abundant and cheap estrone. The only semi-synthesis in which estrone was utilized, was a 
cortistatin core synthesis by the Corey group, where the B-ring was expanded.24 The Baran group 
also attempted to dearomatize estrone in their synthesis of oubagenin.17 They found that the 
original report for the dearomatization at the para-position with a C1 source had incorrectly 
characterized the orthoquinone product 98 as the desired 97 (Figure 31).25  
 
Figure 30. Attempted benzoin condensation of aldehyde 75. 
Figure 31. Baran group structural revision of estrone dearomatization strategy. 
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 A method to dearomatize phenols selectively and in high yields at the para-position with 
a C1 source, known as an angular methyl group, would be a powerful strategy for the synthesis of 
calotropin from estrone, and in general. The known methods to achieve this transformation are 
non-selective, low-yielding, or required biased substrates (Figure 32). The first attempt at 
introducing the angular methyl group was from Woodward, who witnessed installation of a 
dihalomethyl group in the para-position of the phenol 99, as a byproduct of the Reimer-Tiemann 
reaction (Figure 32A).26 The ortho-formylated product 100 consisted of the majority of the product 
distribution. A higher yielding strategy is the oxidative dearomatization of phenol with PhI(OAc)2 
as the oxidant, and an allylsilane as the nucleophile (Figure 32B).27 The requirement for this 
reaction to occur selectively is the use of ortho blocking groups. High yields are only achieved 
when tert-butyl groups are 
used in both ortho-positions. 
The last known strategy is the 
nucleophilic dearomatization 
of phenols with allyl halides as 
the electrophile in the presence 
of silver salts (Figure 32C).28 
This was used to synthesize a 
starting material for another 
methodology and was low-
yielding due to the preferential 
ortho-Friedel Crafts 
alkylation. The allyl group can 
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Figure 32. Installation of angular methyl group. A - Reimer 
Tiemann byproduct; B - oxidative dearomatization; C - 
nucleophilic dearomatization. 
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be considered a protected C1 carbon source. The aldehyde can be revealed through isomerization 
of the terminal olefin, followed by oxidative cleavage of the internal olefin.  
 The retrosynthetic analysis for the semi-synthesis of calotropin from estrone using the 
dearomatization strategy is shown below in Figure 33. The first disconnections removing the 
dideoxy sugar and butenolide are the same as the retrosynthesis in Chapter 2.3, which takes 
calotropin back to diol 130. The diol can be traced back to dienone 104 through the removal of the 
oxidation at C14. Dienone 104 can then be envisioned as a dearomatized product of estrone.  
 The dearomatization of estrone A ring is reminiscent of the biosynthesis of estrone in 
reverse, from commercially available androstenedione (Figure 34).29 Androstenedione is oxidized 
by a P450 cytochrome enzyme at the C19 position to 19-hydroxyandrostenedione, which is also 
commercially available. This would be a desirable intermediate to reach in the semisynthesis and  
Figure 33. Retrosynthetic analysis for semisynthesis from estrone. 
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allows for the parallel exploration of the dearomization strategy and further synthesis of calotropin 
from the dearomatized intermediate. 19-hydroxyandrostenedione is further oxidized by P450s 
twice to release formic acid and aromatize the A ring to yield estrone. 
 
 
 
 
 
 
 
 
2.6. ESTRONE DEAROMATIZATION 
With the start point for the nucleophilic dearomatization of the tetrahydronaphthol 99 using 
allyl bromide and silver salts in Figure 32C, an optimization was attempted. The silver salt 
abstracts the halide, generating a soft allyl cation electrophile. Attack of the phenol should in 
theory occur at the para-position, where the highest HOMO coefficient should reside, furthest 
away from the hard oxygen functionality.  
Optimization began with the 
standard conditions as reported by the Xie 
group (Table 1 Entry A).28 The crude NMR 
was extremely difficult to interpret. Desired 
product peaks could not be distinguished 
from byproducts, so purification was necessary, and isolated yields were determined for screens. 
Change of order of addition to addition of allyl bromide last (entry B) improved the yield from 8% 
to 17%, which was closer to the reported yield of 19%. Increased equivalents of both silver and 
allyl bromide asymptotically increased the yield to 21% at 2 equivalents although this made 
Figure 34. Biosynthesis of estrone from androstenedione. 
Table 1. Order of addition experiments. 
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purification of the product more difficult (Table 2). Many more side products were seen by TLC, 
with close Rf’s to the desired product, although they weren’t characterized by NMR.  
The stoichiometry was kept at 2 equivalents 
of both silver and allyl bromide from this 
point to maximize the yield of desired 
product. The reaction temperature was then 
explored (Table 3). The yield decreased 
exponentially as the temperature was 
increased from 0°C. Temperatures lower than 0 °C were not explored at this point, since water was 
the solvent. 
 
Different allyl halides were then explored, with allyl bromide shown to be the best in terms 
of yield, and availability (Table 4). It also seemed like the more concentrated the reaction, the 
higher the yield (Table 5). 
  
 
 
 
Table 2. Stoichiometry of reagents. 
Table 3. Reaction temperature. Table 4. Allyl halides. 
Table 5. Concentration. 
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The role of Brønsted bases was explored 
(Table 6). When amine bases were added (Entries 
s and t), Ag(0) crashed out of solution and coated 
the walls of the vials immediately. When 
hydroxide bases were used, black precipitate, 
presumably Ag2O crashed out of solution. The 
yields of the reactions in the presence of 
hydroxide base were lower than without. It was hypothesized that having a bulky 
tetrabutylammonium counterion associated with the phenoxide could block ortho-position, 
resulting in selective para-functionalization, but the yield of desired product was as low as using 
NaOH.    
 Slow addition of allyl bromide over 30 minutes was attempted, but the small volume made 
it very difficult to portion (Table 7). It is also immiscible with water, so a stock solution could not 
be made. An aqueous solution of silver nitrate was prepared and added slowly over 30 minutes. 
Neither of these experiments lead to an improved yield over a single addition.  
 
 
 
 
 
  
Table 6. Brønsted bases. 
Table 7. Slow addition. 
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A series of organic solvents 
were screened (Table 8). HFIP and 
TFE, solvents known to stabilize 
charged intermediates, were tested, 
with only TFE (Entry x) giving 
product. No other organic solvent 
gave notable results. Mixtures of 
solvents miscible with water were also 
tested. A 1:1 mixture of dioxane and 
water (Entry ak) gave product. 
 
 
  
Different silver salts were screened (Table 
9). None of gave as high of a yield as 
AgNO3, but Ag2CO3 (Entry az) and AgOAc 
(Entry ay) were close. 
 An organic solvent with low melting 
point, toluene was chosen, and temperatures 
lower than 0 °C were tested (Table 10). 0 °C 
proved to be the optimal temperature to run 
this reaction (Entry be).  
HO
Br (2.0 eq.)
O
Solvent
Ag2O
AgOTF
AgTFA
AgBF4
AgClO4
AgPF6
AgSbF6
AgNTf2-MeCN
Ag(fod)
AgOAc
Ag2CO3
AgOBz
AgNPhth
% yield (isolated)
12%
8%
0%
0%
0%
0%
0%
0%
11%
13%
15%
0%
0%
Entry
ap
aq
ar
as
at
au
av
aw
ax
ay
az
ba
bb
AgX (2.0 eq.)
H2O (0.5 M), 0 °C, 1 h
Table 8. Organic solvents and solvent mixtures. 
Table 9. Silver salts. 
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 Optimizations attempts for this silver-mediated nucleophilic dearomatization did not result 
in yields higher than reported and there was no reduction in the number of observed byproducts. 
The best set of conditions were tested on ketal-protected estrone to see if the reaction would work 
at all, but no desired product was detected (Figure 35). 
 
 
 
 
 
 Dearomatizations of estrone and phenols at the para-position with oxygen has been very 
well characterized.30,31 Estrone and estrogen are shown to have anti-oxidant properties, and capture 
hydroxyl radicals at the C10 position selectively.32 This position was calculated to be the radical 
frontier position. Carbon-centred radicals generated in a reaction mixture in the presence of estrone 
should also go to this position.  
 A transformation that generates carbon centred radicals are the Zn-sulfinate radical C-H 
functionalization of heterocycles developed by the Baran group.33 There were no phenols reported 
in the substrate scope, so this methodology was tried on naphthol 99 (Figure 36). No reaction 
occurred, and there was near quantitative recovery of starting material.  
HO
Br (2.0 eq.)
O
x
-78
-20
0
40
% yield (isolated)
0%
10%
15%
0%
Entry
bc
bd
be
bf
AgNO3 (2.0 eq.)
PhMe (0.5 M), x °C, 1 h
Table 10. Low temperatures. 
HO
Br (2.0 eq.)
O
AgNO3 (2.0 eq.)
PhMe or H2O (0.5 M),
0 °C, 1 h
O
OMe
H
H
H
O
O
H
H
H
H
0%
Figure 35. Nucleophilic dearomatization of protected estrone. 
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2.7. FUTURE DIRECTIONS 
 Future work on this project can focus on the generation of carbon centered radicals for the 
dearomative functionalization of estrone, or the generation of a radical on estrone at C10. 
Dearomative hydroxylation of the para-position followed by formation of a Barton ester or redox-
active ester forms a radical precursor that can be functionalized with photoredox coupling or nickel 
catalysis (Figure 37).34 
  Another potential way to dearomatize estrone with an allyl group, is to allylate at another 
position, then isomerize to the para-position with multiple [3,3]-rearrangements.35 
 The route from 19-hydroxyandrostenedione to calotropin must also be determined and 
optimized. The steps to installation oxidation at C17, the butenolide, and dideoxy sugar have been 
done on similar systems, but reducing the number of steps in these sequences is highly desirable.   
Figure 36. Dearomative trifluoromethylation of naphthol 99. 
Figure 37. Formation of radical at C10 of estrone. 
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APPENDIX: SUPPLEMENTARY INFORMATION 
 
Mononuclear arene cycloaddition 
 
 
 
 
MTAD (1, 113.1 mg, 1.0 mmol, 1.0 eq.) was placed in a test tube. Ethyl acetate (10 mL, 0.1 M) 
was added to the test tube at – 78 ºC, followed by the addition of arene (10 mmol, 10 eq.). The 
mixture was then stirred under the irradiation with LED lights at –78 ºC until full decolorization 
of the reaction mixture was observed (pink solution to colorless solution). At –78 ºC, potassium 
azodicarboxylate (582.7 mg, 3.0 mmol, 3.0 eq.) was added in one portion, followed by the addition 
of acetic acid (0.86 mL, 15 mmol, 15 eq.) in ethyl acetate (4.0 mL). After stirring the resulting 
suspension at –50 ºC for 5 h, the reaction was warmed up to rt in a water bath, then quenched with 
water (2 mL). Saturated aqueous sodium bicarbonate solution (7.5 mL) was added, and then the 
organic phase was separated. The aqueous phase was extracted with ethyl acetate (3 × 10 mL). 
The combined organic layer was washed with saturated aqueous sodium chloride solution (15 mL), 
dried over anhydrous magnesium sulfate, and concentrated in vacuo. After a short column of the 
crude material to remove the excess arene, the ratio of a to b was determined by 1H NMR analysis.  
The mixture of compound a and b was then isolated by flash column chromatography (SiO2, n-
hexane/EtOAc mixture). For the spectroscopic characterizations of compound 3, column-
inseparable mixtures of solid products a and b were further purified by recrystallization from n-
hexane/ethyl acetate mixtures, and only the major product 3 was characterized. For column-
separable mixtures, both products a and b compounds were further separated by column 
chromatography, and characterized individually. 
 
Synthesis of 6: The title compound was isolated by flash chromatography (SiO2, 
hexanes:EtOAc = 2:1) as a white solid (131.3mg, 68%).   
Rf = 0.18 (n-hexane:EtOAc = 2:1, UV, KMnO4).   
1H NMR: (500 MHz, CDCl3) δ 6.42 (dd, J = 4.3, 3.1 Hz, 2H), 4.85 (ddd, J = 4.3, 3.1, 1.8 Hz, 
2H), 3.00 (s, 3H), 2.20 – 2.11 (m, 2H), 1.56 (ddd, J = 11.2, 3.5, 1.8 Hz, 2H).   
13C NMR: (126 MHz, CDCl3) δ 158.1, 130.4, 50.2, 25.4, 22.1.   
HRMS: (ESI-TOF, m/z) calcd. For C9H11KN3O2 [M+K]+ calc.: 232.0483; found: 232.0474.   
32 
 
IR: (ATR, neat, cm-1) 2945 (w), 1771 (m), 1697 (s), 1459 (s), 1435 (s), 1385 (m), 1197 (s), 1175 
(m), 909 (m), 851 (m), 769 (s), 727 (s), 697 (s), 645 (w), 554 (s).   
m.p.: 105 – 106 ºC. 
  
 
Synthesis of 7: The reaction was conducted following the general procedure, except 
the acetic acid was added with methanol (4.0 mL), and the reaction was then slowly 
warmed up to rt. The title compound was isolated by flash chromatography (SiO2, 
hexanes:EtOAc = 4:1) as a light yellow solid (94.0 mg, 45%).   
Rf = 0.24 (SiO2, hexanes:EtOAc = 2:1, UV, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 5.96 (dd, J = 5.8, 1.8 Hz, 1H), 4.77 – 4.68 (m, 1H), 4.60 (ddd, J 
= 3.8, 2.1, 1.7 Hz, 1H), 2.96 (s, 3H), 2.07 – 2.09 (m, 2H), 1.84 (d, J = 1.7 Hz, 3H), 1.54 – 1.43 
(m, 2H).  
13C NMR: (126 MHz, CDCl3) δ 158.3, 158.2, 140.4, 122.3, 54.6, 51.1, 25.4, 23.2, 21.7, 19.5.  
HRMS: (ESI-TOF, m/z) calcd. For C10H13N3NaO2 [M+Na]+ calc.: 230.0900; found: 230.0904.  
IR: (ATR, neat, cm-1) 2947 (w), 1770 (m), 1694 (s), 1456 (s), 1392 (m), 1208 (s), 1022 (w), 712 
(s), 876 (m), 334 (s), 511 (m).  
m.p.: 117 – 119 ºC 
 
Synthesis of 8: Following the general procedure, the title compound was isolated by 
flash chromatography (SiO2, hexanes:EtOAc = 4:1) as a light yellow solid (192.0 mg, 
77%).   
Rf = 0.60 (SiO2, hexanes:EtOAc = 1:1, UV, KMnO4).   
1H NMR: (500 MHz, CDCl3) δ 5.99 (dd, J = 5.9, 2.5 Hz, 1H), 4.92 (dt, J = 2.5, 2.5 Hz, 1H), 4.81 
(dt, J = 5.9, 3.0 Hz, 1H), 2.97 (s, 3H), 2.19 (ddt, J = 12.5, 9.4, 2.5 Hz, 1H), 2.11 (ddt, J = 12.5, 
9.4, 3.0 Hz, 1H), 1.53 (tt, J = 12.1, 3.0 Hz, 1H), 1.43 (tt, J = 12.1, 2.5 Hz, 1H), 1.04 (s, 9H).  
13C NMR: (126 MHz, CDCl3) δ 157.6, 156.7, 153.1, 119.0, 51.0, 50.4, 33.4, 28.0, 25.3, 23.4, 23.2.  
HRMS: (ESI-TOF, m/z) calcd. For C13H20N3O2 [M+H]+ calc.: 250.1556; found: 250.1548.  
IR: (ATR, neat, cm-1) 2968 (w), 1769 (m), 1699 (s), 1630 (w), 1462 (m), 1396 (m), 1366 (m), 
1216 (m), 1165 (w), 1024 (w), 923 (w), 856 (w), 764 (m), 697 (w), 573 (w)  
m.p.: 107 – 108 ºC 
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Synthesis of 9: Following the general procedure using dichloromethane instead of ethyl 
acetate as solvent, the title compound was isolated by flash chromatography (SiO2, 
hexanes:EtOAc = 4:1) as a light yellow solid (94.5 mg, 42%).   
Rf = 0.39 (SiO2, hexanes:EtOAc = 2:1, UV, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 6.29 (dd, J = 6.2, 2.2 Hz, 1H), 4.88 (dt, J = 5.9, 2.8 Hz, 1H), 4.84 
– 4.82 (m, 1H), 2.99 (s, 3H), 2.22 – 2.09 (m, 2H), 1.75 (m, 1H), 1.58 (m, 1H).  
13C NMR: (126 MHz, CDCl3) δ 157.7, 157.4, 131.8, 124.6, 56.8, 51.7, 25.3, 22.6, 22.3.  
HRMS: (ESI-TOF, m/z) calcd. For C9H10N3O2Cl [M]+ calc.: 227.0462; found: 227.0467.  
IR: (ATR, neat, cm-1) 3076 (w), 2943 (w), 1768 (m), 1714 (s), 1610 (m), 1444 (s), 1013 (m), 849 
(m), 766 (s), 533 (m), 521 (m).  
m.p.: 110 – 111 ºC. 
 
Synthesis of 10: Following the general procedure, the title compound was isolated as 
a mixture with 10’ by flash chromatography (SiO2, hexanes:EtOAc = 2:1) as a light 
yellow solid (184.0 mg, 69%, 10:10’ = 1.3:1). The isomers were further separated by 
flash chromatography (SiO2, hexanes:EtOAc = 2:1) for analytical purposes.  
Rf = 0.50 (SiO2, hexanes:EtOAc = 1:1, UV, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 6.57 (dd, J = 5.5, 1.4 Hz, 1H), 4.83 (td, J = 2.9, 1.4 Hz, 1H), 4.78 
(dt, J = 5.5, 2.8 Hz, 1H), 2.97 (s, 3H), 2.24 – 2.04 (m, 2H), 1.60 – 1.45 (m, 1H), 1.44 – 1.31 (m, 
1H), 0.09 (s, 9H).  
13C NMR: (126 MHz, CDCl3) δ 158.2, 157.8, 146.0, 137.1, 52.4, 50.4, 25.4, 22.1, 22.0, –2.5.  
HRMS: (ESI-TOF, m/z) calcd. For C12H19N3O2Si [M]+ calc.: 265.1247; found: 265.1243.  
IR: (ATR, neat, cm-1) 2953 (w), 1706 (s), 1451 (s), 1388 (m), 1262 (m), 1202 (s), 1037 (m), 871 
(m), 831 (s), 809 (m), 768 (m), 753 (s), 603 (m), 563 (m), 498 (m).  
m.p.: 76 – 78 ºC. 
 
Rf = 0.40 (SiO2, hexanes:EtOAc = 1:1, UV, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 6.48 (ddd, J = 8.1, 5.7, 1.5 Hz, 1H), 6.33 (ddd, J = 
8.1, 5.7, 1.5 Hz, 1H), 4.84 (ddd, J = 5.7, 2.8, 1.5 Hz, 1H), 4.77 (ddd, J = 5.7, 1.7, 1.6 
Hz, 1H), 2.96 (s, 3H), 2.04 (ddd, J = 13.0, 5.0, 1.7 Hz, 1H), 1.63 (ddd, J = 13.0, 11.8, 2.8 Hz, 1H), 
0.83 (ddd, J = 11.8, 5.0, 1.6 Hz, 1H), 0.09 (s, 9H).  
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13C NMR: (126 MHz, CDCl3) δ 158.3, 157.9, 132.5, 128.5, 51.4, 50.8, 25.4, 24.4, 21.5, –2.6.  
HRMS: (ESI-TOF, m/z) calcd. For C12H19N3O2Si [M]+ calc.: 265.1247; found: 265.1250.  
IR: (ATR, neat, cm-1) 2952 (w), 1766 (m), 1698 (s), 1454 (m), 1393 (m), 1249 (m), 1212 (m), 885 
(m), 831 (s), 766 (s), 753 (s), 709 (m), 685 (s), 529 (m).  
m.p.: 77 – 80 ºC. 
 
Synthesis of 11: Following the general procedure the title compound was isolated 
by flash chromatography (SiO2, hexanes:EtOAc = 2:1) as a light yellow solid (165.9 
mg, 59%).  
Gram-scale synthesis of 11: MTAD (2.00 g, 17.7 mmol, 1.0 eq.) was placed in a 500 mL 
borosilicate bottle. Ethyl acetate (150 mL, 0.12 M) was added to the test tube at – 78 ºC, followed 
by the addition of phenethyl acetate (28.1 mL, 176.9 mmol, 10 eq.). The mixture was then stirred 
under irradiation with LED lights at –78 ºC until full decolorization of the reaction mixture was 
observed (pink to colorless solution). The lights were turned off and potassium azodicarboxylate 
(10.3 g, 53.1 mmol, 3.0 eq.) was added in one portion at –78 ºC, followed by the addition of acetic 
acid (15.2 mL, 265.3 mmol, 15 eq.) in ethyl acetate (30.0 mL) over 20 minutes. After stirring the 
resulting suspension at –50 ºC for 12 h, the reaction was warmed up to rt in water bath, then slowly 
quenched with water (50 mL). The organic phase was separated, and the aqueous phase was 
extracted with ethyl acetate (3 × 200 mL). The combined organic layer was washed with saturated 
aqueous sodium chloride solution (200 mL), dried over anhydrous magnesium sulfate, and 
concentrated in vacuo. The product was purified by column chromatography (SiO2, 
hexanes/EtOAc = 2:1) to yield the desired product 11 (3.36 g, 68%).  
Rf = 0.17 (SiO2, hexanes:EtOAc = 1:1, UV, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 6.12 (d, J = 5.6 Hz, 1H), 4.85 (dt, J = 5.6, 2.5 Hz, 1H), 4.77 (dt, 
J = 2.3, 2,3 Hz, 1H), 4.28 (dt, J = 11.1, 6.1 Hz, 1H), 4.12 (ddd, J = 11.1, 7.7, 5.8 Hz, 1H), 3.04 
(s, 3H), 2.59 – 2.44 (m, 2H), 2.24 – 2.14 (m, 2H), 2.06 (s, 3H), 1.63 – 1.54 (m, 2H). 
13C NMR: (126 MHz, CDCl3) δ 170.6, 158.0, 157.8, 140.4, 124.3, 61.5, 53.4, 50.7, 32.4, 25.2, 
22.7, 21.9, 20.8.  
HRMS: (ESI-TOF, m/z) calcd. For C13H18N3O4 [M+H]+ calc.: 280.1297; found: 280.1293.  
IR: (ATR, neat, cm-1) 2954 (w), 1738 (s), 1702 (s), 1464 (m), 1450 (m), 1386 (m), 1250 (s), 1220 
(s), 1182 (m), 1028 (m), 963 (m), 857 (w), 764 (w), 530 (w), 460 (w).  
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m.p.: 66 – 68 ºC   
 
Synthesis of 12: Following the general procedure, using dichloromethane instead 
of ethyl acetate as solvent and 3 eq. of starting arene, the title compound was 
isolated by flash chromatography (SiO2, hexanes:EtOAc = 2:1) as a white solid 
(165  mg, 45%).   
Rf = 0.09 (SiO2, hexanes:EtOAc = 2:1, UV, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 7.82 (dd, J = 5.5, 3.1 Hz, 2H), 7.71 (dd, J = 5.5, 3.1 Hz, 2H), 6.06 
(ddd, J = 5.9, 1.6 Hz, 1H), 4.78 – 4.73 (m, 2H), 3.84 (ddd, J = 13.7, 8.2, 7.1 Hz, 1H), 3.67 (ddd, 
J = 13.7, 8.2, 5.7 Hz, 1H), 2.97 (s, 3H), 2.62 – 2.46 (m, 2H), 2.17 – 2.05 (m, 2H), 1.68 – 1.58 (m, 
1H), 1.45 (ddd, J = 11.9, 9.1, 2.6 Hz, 1H).   
13C NMR: (126 MHz, CDCl3) δ 168.1, 158.1, 157.9, 140.8, 134.2, 132.0, 124.2, 123.4, 53.7, 50.9, 
35.8, 32.1, 25.5, 22.9, 22.1.   
HRMS: (ESI-TOF, m/z) calcd. For C19H18N4O4 [M]+ calc.: 366.1328; found: 366.1329.  
IR: (ATR, neat, cm-1) 2944 (w), 1770 (m), 1702 (s), 1398 (m), 1199 (m), 1010 (m), 769 (m), 723 
(s), 531 (m).  
m.p.: 186 – 188 ºC 
 
Synthesis of 13: Following the general procedure, the title compound was 
isolated by flash chromatography (SiO2, hexanes:EtOAc = 2:1) as a yellow oil 
(196.2 mg, 67%).   
Rf = 0.17 (SiO2, hexanes:EtOAc = 2:1, UV, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 6.00 (dd, J = 5.5, 1.7 Hz, 1H), 4.80 (dt, J = 5.5, 2.6 Hz, 1H), 4.70 
– 4.65 (m, 1H), 4.11 (q, J = 7.2 Hz, 2H), 2.99 (s, 3H), 2.52 – 2.32 (m, 4H), 2.19 – 2.07 (m, 2H), 
1.62 – 1.47 (m, 2H), 1.24 (t, J = 7.2 Hz, 3H).  
13C NMR: (126 MHz, CDCl3) δ 172.3, 158.3, 158.2, 143.0, 122.4, 60.8, 53.8, 50.9, 31.6, 28.3, 
25.5, 23.1, 22.1, 14.4. 
HRMS: (ESI-TOF, m/z) calcd. For C14H19KN3O4 [M+K]+ calc.: 332.1007; found: 332.0997.  
IR: (ATR, neat, cm-1) 2942 (w), 1701 (s), 1698 (s), 1449 (s), 1393 (m), 1191 (m), 1175 (m), 1162 
(m), 1044 (m), 1021 (m), 918 (w), 854 (w), 767 (s), 581 (w), 547 (m). 
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Synthesis of 14: Following the general procedure, the title compound was isolated 
by flash chromatography (SiO2, hexanes:EtOAc = 1:1) as a light yellow solid (160.2 
mg, 60%).   
Rf = 0.40 (SiO2, hexanes:EtOAc = 1:2, UV, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 6.28 (ddd, J = 5.9, 1.6 Hz, 1H), 4.86 (ddt, J = 5.9, 3.0, 1.2 Hz, 
1H), 4.80 (dd, J = 1.6 Hz, 1H), 4.66 (dd, J = 13.6, 1.6 Hz, 1H), 4.55 (dd, J = 13.6, 1.5 Hz, 1H), 
2.99 (s, 3H), 2.18 (t, J = 2.6 Hz, 1H), 2.17 – 2.14 (m, 1H), 2.09 (s, 3H), 1.59 – 1.52 (m, 2H).  
13C NMR: (126 MHz, CDCl3) δ 170.6, 158.2, 158.0, 138.8, 125.4, 62.7, 51.4, 50.5, 25.3, 22.6, 
22.1, 20.8.  
HRMS: (ESI-TOF, m/z) calcd. For C12H15N3O4 [M]+ calc.: 265.1063; found: 265.1060.  
IR: (ATR, neat, cm-1) 2944 (w), 1740 (m), 1699 (s), 1451 (m), 1393 (w), 1218 (s), 1027 (m), 912 
(m), 767 (m), 729 (s).  
m.p.: 57 – 58 ºC   
 
 
Synthesis of 15: Following the general procedure using racemic 1-phenylethyl 
acetate, the title compound was isolated by flash chromatography (SiO2, 
hexanes:EtOAc = 2:1) as a light yellow solid (162.4 mg, 58%, dr = 1.7:1).   
Rf = 0.24 (SiO2, hexanes:EtOAc = 1:1, UV, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 6.15 (m, 1H major, 1H minor), 5.28 (qd, J = 6.6, 1.3 Hz, 1H 
major), 5.15 (qd, J = 6.8, 1.2 Hz, 1H minor), 4.83 – 4.69 (m, 2H major, 2 H minor), 2.91 (s, 3H 
major), 2.87 (s, 3H minor), 2.21 – 2.00 (m, 2H major, 2H minor), 1.98 (d, J = 0.9 Hz, 3H major, 
3H minor), 1.57 – 1.31 (m, 2H major, 2H minor), 1.24 (dd, J = 6.7, 0.9 Hz, 3H major, 3H minor).  
13C NMR: (126 MHz, CDCl3) δ 170.1 (major), 170.1 (minor), 158.1 (minor), 158.0 (major), 157.7 
(minor), 157.5 (major), 143.4 (minor), 143.0 (major), 123.4 (major), 123.4 (minor), 69.1 (minor), 
68.4 (major), 50.8 (major), 50.6 (minor), 50.3 (minor), 50.2 (major), 25.2 (major), 25.1 (minor), 
22.8 (minor), 22.5 (major), 22.5 (minor), 22.4 (major), 21.1 (minor), 20.9 (major), 19.1 (minor), 
18.3 (major).  
HRMS: (ESI-TOF, m/z) calcd. For C13H17N3O4 [M+H]+ calc.: 279.1219; found: 279.1218.  
IR: (ATR, neat, cm-1) 2968 (w), 1769 (m), 1699 (s), 1630 (w), 1462 (m), 1396 (m), 1366 (m), 
1216 (m), 1165 (w), 1024 (w), 923 (w), 856 (w), 764 (m), 697 (w), 573 (w).  
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m.p.: 86 – 88 ºC 
 
Synthesis of 16: Following the general procedure, the title compound was isolated 
by flash chromatography (SiO2, hexanes:EtOAc = 2:1) as a yellow oil (128.1 mg, 
48%).   
Rf = 0.14 (SiO2, hexanes:EtOAc = 1:1, UV, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 6.31 (dt, J = 5.9, 1.6 Hz, 1H), 4.84 – 4.82 (m, 2H), 4.70 (d, J = 
1.4 Hz, 1H), 3.24 (s, 3H), 3.17 (s, 3H), 2.91 (s, 3H), 2.12 – 2.07 (m, 2H), 1.53 – 1.47 (m, 2H).  
13C NMR: (126 MHz, CDCl3) δ 157.9, 157.5, 140.5, 125.9, 101.5, 54.2, 53.2, 50.5, 50.4, 25.5, 
22.9, 22.5.  
HRMS: (ESI-TOF, m/z) calcd. For C12H17N3O4Na [M+Na]+ calc.: 290.1117; found: 290.1113.  
IR: (ATR, neat, cm-1) 2942 (w), 2832 (w), 1774 (m), 1699 (s), 1447 (m), 1392 (m), 1193 (m), 
1018 (m), 1053 (m), 909 (w), 766 (m), 547 (m).  
  
Synthesis of 17: Following the general procedure, the title compound was isolated 
by flash chromatography (SiO2, hexanes:EtOAc = 2:1) as a light yellow oil (164.0 
mg, 58%).   
Rf = 0.24 (SiO2, hexanes:EtOAc = 1:1, UV, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 6.43 (dd, J = 5.4, 1.9 Hz, 1H), 4.99 (d, J = 2.4 Hz, 1H), 4.92 (dt, 
J = 5.4, 2.2 Hz, 1H), 3.14 (s, 3H), 3.12 (s, 3H), 2.99 (s, 3H), 2.23 – 2.13 (m, 2H), 1.60 – 1.54 (m, 
2H), 1.37 (s, 3H).  
13C NMR: (126 MHz, CDCl3) δ 157.4, 156.9, 144.4, 125.5, 99.5, 50.6, 50.1, 49.3, 49.1, 25.4, 23.0, 
22.8, 22.6.  
HRMS: (ESI-TOF, m/z) calcd. For C13H23N4O4 [M+NH4]+ calc.: 299.1714; found: 299.1716.  
IR: (ATR, neat, cm-1) 2944 (w), 1767 (m), 1699 (s), 1449 (s), 1393 (s), 1188 (s), 1143 (s), 1106 
(m), 1033 (s), 873 (m), 856 (m), 765 (s), 696 (m), 557 (m). 
 
Synthesis of 18: Following the general procedure, the title compound was isolated 
by flash chromatography (SiO2, hexanes:EtOAc = 2:1) as a light yellow oil (159.3 
mg, 54%).   
Rf = 0.14 (SiO2, hexanes:EtOAc = 1:1, UV, KMnO4).  
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1H NMR: (500 MHz, CDCl3) δ 6.52 (dd, J = 5.9, 1.8 Hz, 1H), 4.97 (dd, J = 2.2 Hz, 1H), 4.90 (dt, 
J = 5.9, 2.4 Hz, 1H), 3.08 (s, 9H), 2.93 (s, 3H), 2.13 (m, 2H), 1.56 – 1.50 (m, 2H).  
13C NMR: (126 MHz, CDCl3) δ 156.6, 155.9, 138.6, 129.3, 112.7, 50.0, 49.9, 49.4, 25.3, 23.1, 
22.6.  
HRMS: (ESI-TOF, m/z) calcd. For C13H19N3O5Na [M+Na]+ calc.: 320.1220; found: 320.1222.  
IR: (ATR, neat, cm-1): 2947 (w), 1772 (w), 1709 (s), 1446 (m), 1394 (m), 1211 (m), 1086 (s), 1068 
(s), 920 (w), 871 (w), 763 (m), 543 (w).  
  
Synthesis of 19: Following the general procedure, the title compound was isolated 
by flash chromatography (SiO2, hexanes:EtOAc = 2:1) as a light yellow solid (183.0 
mg, 64%).   
Rf = 0.27 (SiO2, hexanes:EtOAc = 2:1, UV, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 6.30 (dt, J = 6.1, 1.6 Hz, 1H), 4.83 (m, 2H), 3.99 (dd, J = 10.8, 
1.6 Hz, 1H), 3.90 (dd, J = 10.8, 0.8 Hz, 1H), 2.95 (s, 3H), 2.22 – 2.14 (m, 2H), 1.66 – 1.54 (m, 
2H).  
13C NMR: (126 MHz, CDCl3) δ 157.9, 157.7, 139.5, 126.0, 53.1, 50.9, 30.5, 25.4, 22.9, 22.8.  
HRMS: (ESI-TOF, m/z) calcd. For C10H12N3O2Br [M]+ calc.: 285.0113; found: 285.0112.  
IR: (ATR, neat, cm-1) 2944 (w), 2249 (w), 1771 (m), 1695 (s), 1450 (s), 1392 (m), 1202 (m), 1016 
(w), 912 (m), 765 (m), 728 (m).  
m.p.: 108 – 110 ºC. 
 
Synthesis of 20: Following the general procedure, the title compound was isolated 
by flash chromatography (SiO2, hexanes:EtOAc = 2:1) as a colorless oil (194.2 
mg, 66%).   
Rf = 0.45 (SiO2, hexanes:EtOAc = 1:2, UV, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 6.19 (dd, J = 6.0, 2.1 Hz, 1H), 4.89 – 4.86 (m, 2H), 3.67 (s, 3H), 
2.98 (s, 3H), 2.21 – 2.09 (m, 2H), 1.64 – 1.51 (m, 2H), 1.34 (s, 3H), 1.32 (s, 3H).  
13C NMR: (126 MHz, CDCl3) δ 175.0, 157.3, 156.5, 146.8, 122.3, 52.4, 51.7, 50.1, 45.0, 25.2, 
24.3, 23.4, 23.1, 22.9.   
HRMS: (ESI-TOF, m/z) calcd. For C14H19N3O4 [M+H]+ calc.: 294.1446; found: 294.1454. 
X
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IR: (ATR, neat, cm-1): 2946 (w), 1769 (m), 1696 (s), 1450 (m), 1392 (m), 1210 (m), 1019 (w), 
913 (m), 727 (s), 571 (m).   
m.p.: 105 ºC 
 
Synthesis of 21: Following the general procedure, the title compound was isolated 
by flash chromatography (SiO2, hexanes:EtOAc = 2:1) as a light yellow solid (190.0 
mg, 67%).   
Rf = 0.55 (SiO2, hexanes:EtOAc = 1:2, UV, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 6.14 (dd, J = 6.0, 2.1 Hz, 1H), 4.89 – 4.83 (m, 2H), 3.51 (d, J = 
11.1 Hz, 1H), 3.42 (d, J = 11.1 Hz, 1H), 2.97 (s, 3H), 2.25 – 2.06 (m, 2H), 1.64 – 1.48 (m, 2H), 
1.15 (s, 3H), 1.14 (s, 3H).  
13C NMR: (126 MHz, CDCl3) δ 157.7, 157.2, 147.2, 123.5, 52.3, 50.4, 50.3, 38.4, 25.2, 24.0, 23.8, 
23.1, 22.6.   
HRMS: (ESI-TOF, m/z) calcd. For C13H18N3O2Cl [M]+ calc.: 283.1088; found: 283.1088. 
IR: (ATR, neat, cm-1) 2946 (w), 1769 (m), 1696 (s), 1450 (m), 1392 (m), 1210 (m), 1019 (w), 913 
(m), 830 (m), 727 (s), 571 (m).   
m.p.: 97 – 98 ºC.  
  
Synthesis of 22: Following the general procedure, the title compound was isolated 
as a mixture with 22’ by flash chromatography (SiO2, hexanes:EtOAc = 2:1) as a 
colorless oil (215.0 mg, 66%, 22:22’ = 1.9:1).  The constitutional isomers were 
further separated by flash chromatography (SiO2, hexanes:EtOAc = 2:1).  
Rf = 0.21 (SiO2, hexanes:EtOAc = 2:1, UV, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 7.74 (dd, J = 7.7, 0.9 Hz, 1H), 7.49 (dd, J = 7.6, 1.4 Hz, 1H), 7.36 
(dd, J = 7.7, 1.4 Hz, 1H), 7.28 – 7.25 (m, 1H), 6.20 (dd, J = 6.0, 1.9 Hz, 1H), 5.00 (dt, J = 4.4, 2.2 
Hz, 1H), 4.93 (dd, J = 5.7, 2.7 Hz, 1H), 3.81 (s, 3H), 3.02 (s, 3H), 2.26 – 2.20 (m, 2H), 2.07 – 2.01 
(m, 1H), 1.69 (ddd, J = 10.6, 6.0, 3.1 Hz, 1H).  
13C NMR: (126 MHz, CDCl3) δ 168.3, 158.2, 157.9, 142.8, 137.2, 132.0, 130.3, 130.1, 129.3, 
128.3, 125.5, 55.0, 52.3, 51.0, 25.5, 22.7, 22.4.   
HRMS: (ESI-TOF, m/z) calcd. For C17H17N3O4Na [M+Na]+ calc.: 350.1117; found: 350.1111.   
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IR: (ATR, neat, cm-1) 2949 (w), 2252 (w), 1772 (m), 1699 (s), 1447 (m), 1393 (m), 1269 (m), 911 
(m), 756 (m), 727 (m), 545 (w).   
  
The titled compound was isolated as a colorless oil.  
Rf = 0.25 (SiO2, hexanes:EtOAc = 2:1, UV, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 7.41 – 7.35 (m, 5H), 5.47 (t, J = 2.8 Hz, 1H), 5.08 
(t, J = 2.8 Hz, 1H), 3.65 (s, 3H), 3.03 (s, 3H), 2.33 – 2.24 (m, 2H), 1.81 – 1.64 (m, 
2H).   
13C NMR: (126 MHz, CDCl3) δ 164.0, 157.7, 157.5, 150.6, 134.3, 129.5, 128.4, 128.4, 125.7, 
56.4, 52.2, 51.6, 25.7, 22.6, 21.9.   
HRMS: (ESI-TOF, m/z) calcd. For C17H17N3O4Na [M+Na]+ calc.: 350.1117; found: 350.1110.   
IR: (ATR, neat, cm-1) 2950 (w), 2254 (w), 1770 (m), 1703 (s), 1446 (m), 1393 (m), 1225 (m), 916 
(m), 768 (m), 698 (m), 577 (m). 
 
Synthesis of 23: Following the general procedure A, the title compound was isolated 
by flash chromatography (SiO2, hexanes:EtOAc = 4:1) as a light yellow solid (150.3 
mg, 52%).   
Rf = 0.70 (SiO2, hexanes:EtOAc = 1:1, UV, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 5.95 (dd, J = 5.6, 1.7 Hz, 1H), 4.77 (dd, J = 5.6, 2.6 Hz, 1H), 4.64 
(dd, J = 2.6 Hz, 1H), 2.97 (s, 3H), 2.18 – 2.03 (m, 4H), 1.54 – 1.48 (m, 2H), 1.44 – 1.33 (m, 2H), 
1.32 – 1.14 (m, 8H), 0.86 (t, J = 6.9 Hz, 3H).   
13C NMR: (126 MHz, CDCl3) δ 158.2, 157.9, 144.7, 121.6, 53.9, 51.0, 33.4, 31.9, 29.13, 29.07, 
26.7, 25.4, 23.2, 22.7, 22.3, 14.2.   
HRMS: (ESI-TOF, m/z) calcd. For C16H25N3NaO2 [M+Na]+ calc.: 314.1839; found: 314.1830.   
IR: (ATR, neat, cm-1) 2926 (m), 2855 (w), 1772 (m), 1701 (s), 1451 (s), 1393 (m), 1203 (m), 1013 
(m), 912 (w), 766 (m).   
m.p.: 40 – 42 ºC 
 
Synthesis of 24: Following the general procedure A, the title compound was isolated 
by flash chromatography (SiO2, hexanes:EtOAc = 2:1) as a light yellow solid (150.3 
mg, 66%).   
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Rf = 0.41 (SiO2, hexanes:EtOAc = 1:2, UV, KMnO4) 
1H NMR (500 MHz, CDCl3) δ 6.31 (dd, J = 5.7, 1.4 Hz, 1H), 4.87 – 4.84 (m, 2H), 4.12 (dd, J = 
12.5, 1.4 Hz, 1H), 4.04 (dd, J = 12.5, 1.1 Hz, 1H), 2.97 (s, 3H), 2.25 – 2.09 (m, 2H), 1.71 – 1.44 
(m, 2H). 
13C NMR (126 MHz, CDCl3) δ 158.2, 157.8, 139.54, 125.8, 52.4, 50.8, 43.5, 25.5, 22.8, 22.7. 
IR (ATR, neat, cm-1): 2946 (w), 1772 (w), 1695 (s), 1450 (s), 1392 (m), 1202 (m), 1017 (m), 766 
(m), 698 (m), 543 (w). 
HRMS (ESI-TOF, m/z) calcd. For C10H12ClN3O2 [M]+ calc.: 241.0613; found: 241.0619. 
m.p.: 104.7-105.6 °C 
 
Synthesis of 25: Following the general procedure A, the title compound was isolated 
by flash chromatography (SiO2, hexanes:EtOAc = 2:1) as a light yellow solid (120.3 
mg, 23%).   
Rf = 0.61 (SiO2, n-hexane/EtOAc = 1:2, KMnO4) 
1H NMR (500 MHz, CDCl3) δ 7.55 – 7.48 (m, 2H), 7.46 – 7.40 (m, 2H), 7.40 – 7.35 (m, 1H), 6.56 
(dd, J = 5.9, 2.1 Hz, 1H), 5.04 (dt, J = 5.6, 2.6 Hz, 1H), 3.00 (s, 3H), 2.34 – 2.26 (m, 2H), 1.69 
(dt, J = 9.6, 2.1 Hz, 2H). 
13C NMR (126 MHz, CDCl3) δ 158.4, 158.1, 142.9, 134.8, 129.1, 128.8, 125.6, 122.1, 52.6, 51.0, 
25.5, 22.5, 22.3. 
IR (ATR, neat, cm-1): 2942 (w), 1771 (m), 1698 (s), 1446 (s), 1392 (m), 1203 (m), 1018 (w), 911 
(m), 770 (s), 754 (s) 730 (m), 695 (m), 551 (m).  
HRMS (EI-TOF, m/z) calcd. For C15H15N3O2 [M+H]+ calc.: 269.1164; found: 269.1164. 
MP: 142.9 - 144.0 °C 
 
Synthesis of 26: Following the general procedure A, the title compound was isolated 
by flash chromatography (SiO2, hexanes:EtOAc = 2:1) as a light yellow solid (142.4 
mg, 34%).   
Rf = 0.55 (SiO2, n-hexane:EtOAc = 1:2, KMnO4). 
1H NMR (500 MHz, CDCl3) δ 7.89 – 7.81 (m, 2H), 7.56 – 7.49 (m, 1H), 7.50 – 7.43 (m, 2H), 6.15 
(t, J = 2.5 Hz, 1H), 5.39 (t, J = 2.8 Hz, 1H), 2.96 (s, 3H), 2.33 (ddt, J = 12.4, 9.6, 2.6 Hz, 1H), 
2.27 (ddt, J = 12.4, 9.6, 2.6 Hz, 1H), 1.73 (tt, J = 12.4, 2.9 Hz, 1H), 1.65 (tt, J = 12.4, 2.9 Hz, 1H). 
25
X
Ph
42 
 
13C NMR (126 MHz, CDCl3) δ 171.1, 157.9, 157.5, 133.3, 132.1, 129.1, 126.9, 67.1, 48.8, 25.6, 
21.4, 20.0. 
IR (ATR, neat, cm-1): 2946 (w), 1776 (m), 1702 (s), 1595 (m), 1568 (m), 1446 (s), 1392 (m), 1364 
(m), 1194 (m), 1060 (m), 1025 (m), 1013 (m), 916 (m), 793 (m), 764 (m), 718 (s), 690 (m), 645 
(m), 576 (m), 555 (m).  
HRMS (EI-TOF, m/z) calcd. For C14H15N4O2 [M+H]+ calc.: 271.1186; found: 271.1195. 
MP: 162.4 – 163.5 °C 
 
Polynuclear arene cycloaddition 
 
 
 
 
MTAD (1, 113.1 mg, 1.0 mmol, 1.0 eq.) was placed in a test tube. Ethyl acetate (10 mL, 0.1 M) 
was added to the test tube at –78 ºC, followed by the addition of arene (2.0 mmol, 2.0 eq.). If arene 
was a solid, ethyl acetate (5.0 mL) was added to MTAD at –78 ºC, and arene was added as a 
solution in ethyl acetate (5.0 mL). The mixture was then stirred under the irradiation with LED 
lights at –78 ºC until full decolorization of the reaction mixture was observed (pink to colorless 
solution). At –78 ºC, potassium azodicarboxylate (582.7 mg, 3.0 mmol, 3.0 eq.) was added in one 
portion, followed by the addition of acetic acid (0.86 mL, 15 mmol, 15 eq.) in ethyl acetate (4.0 
mL). After stirring the resulting suspension at –50 ºC for 5 h, the reaction was warmed up to rt in 
water bath, then quenched with water (2.0 mL). Saturated aqueous sodium bicarbonate solution 
(7.5 mL) was added, and then the organic phase was separated. The aqueous phase was extracted 
with ethyl acetate (3 × 10 mL). The combined organic layer was washed with saturated aqueous 
sodium chloride solution (15 mL), dried over anhydrous magnesium sulfate, and concentrated in 
vacuo. The crude mixture was purified by flash column chromatography (SiO2, n-hexane/EtOAc 
mixture) to provide cycloadduct. 
 
 Synthesis of 28: Following the general procedure, the title compound was isolated by 
flash chromatography (SiO2, hexanes:EtOAc = 1:1) as a white solid (212.1 mg, 87%).   
Synthesis of 28 on gram-scale: Naphthalene (2.56 g, 20.0 mmol, 2.0 eq.) and MTAD 
(1.13 g, 10.0 mmol, 1.0 eq.) were placed in a 500 mL borosilicate bottle, and ethyl acetate (100 
mL, 0.10 M) was added at –78 ºC. The mixture was then stirred under irradiation with LED lights 
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at –78 ºC until full decolorization of the reaction mixture was observed (pink to colorless solution). 
The lights were turned off and potassium azodicarboxylate (5.83 g, 30.0 mmol, 3.0 eq.) was added 
in one portion at –78 ºC, followed by the addition of acetic acid (8.85mL, 150 mmol, 15 eq.) in 
ethyl acetate (20.0 mL) over 15 minutes. The resulting suspension was immediately placed out of 
the cold bath and stirred at ambient temperature for 5 hours. Water (50 mL) was added and the 
phases were separated. The aqueous phase was extracted with ethyl acetate (3 × 100 mL) and the 
combined organic layer was washed with saturated aqueous sodium chloride solution (100 mL), 
dried over anhydrous magnesium sulfate, and concentrated in vacuo. The product was purified by 
column chromatography (SiO2, hexanes/EtOAc = 5:1 → 1:1). The obtained pale yellow solid was 
recrystallized from diethylether/hexanes to yield the desired product 28 (2.00 g, 82%).  
Rf = 0.35 (SiO2, hexanes:EtOAc = 1:2, UV, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 7.35 (dd, J = 5.4, 3.3 Hz, 2H), 7.29 (dd, J = 5.4, 3.3 Hz, 2H), 
5.30 – 5.28 (m, 2H), 2.84 (s, 3H), 2.42 – 2.36 (m, 2H), 1.73 – 1.68 (m, 2H).   
13C NMR: (126 MHz, CDCl3) δ 156.9, 134.9, 128.8, 123.4, 53.8, 25.2, 23.5.   
HRMS: (ESI-TOF, m/z) calcd. For C13H13N3O2 [M]+ calc.: 243.1007; found: 243.1008.   
IR: (ATR, neat, cm-1) 2942 (w), 1764 (m), 1698 (s), 1458 (s), 1436 (s), 1395 (s), 1237 (m), 1204 
(s), 1165 (m), 1069 (w), 1037 (m), 988 (m), 946 (m), 915 (m), 753 (s), 593 (m), 538 (s).   
m.p.: 190 – 191 ºC. 
 
Synthesis of 29: Following the general procedure, the title compound was isolated 
by flash chromatography (SiO2, hexanes:EtOAc = 2:1, 1% Et3N) as a white solid 
(220.0 mg, 66%).  
Rf = 0.57 (SiO2, hexanes:EtOAc = 1:2, UV, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 7.56 (dd, J = 8.1, 1.3 Hz, 1H), 7.30 (dd, J = 8.1, 7.3 Hz, 1H), 7.21 
(dd, J = 7.3, 1.3 Hz, 1H), 6.16 (t, J = 2.5 Hz, 1H), 5.27 (t, J = 2.3 Hz, 1H), 3.25 (s, 3H), 3.23 (s, 
3H), 2.87 (s, 3H), 2.37 – 2.34 (m, 2H), 1.73 – 1.68 (m, 2H), 1.67 (s, 3H).   
13C NMR: (126 MHz, CDCl3) δ 156.3, 155.6, 138.0, 136.1, 133.5, 128.0, 127.5, 123.4, 102.1, 
53.7, 50.5, 49.2, 49.2, 26.0, 25.3, 23.8, 23.4.   
HRMS: (ESI-TOF, m/z) calcd. For C17H21N3O4Na [M+Na]+ calc.: 354.1430; found: 354.1428.   
IR: (ATR, neat, cm-1) 2945 (w), 2249 (w), 1764 (m), 1700 (s), 1453 (m), 1394 (m), 1275 (m), 
1206 (m), 1146 (m), 1038 (m), 876 (m), 762 (m), 729 (m), 562 (m).   
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m.p.: 168 – 169 ºC.  
 
 Synthesis of 30: Following the general procedure, the title compound was 
isolated by flash chromatography (SiO2, hexanes:EtOAc = 2:1) as a white solid 
(136.4 mg, 43%).  
Rf = 0.53 (SiO2, hexanes:EtOAc = 1:2, UV, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 7.61 – 7.54 (m, 3H), 7.51 (d, J = 1.8 Hz, 1H), 7.47 – 7.41 (t, J = 
7.6 Hz, 2H), 7.36 (dt, J = 7.6, 3.5 Hz, 2H), 5.37 – 3.33 (m, 2H), 2.86 (s, 3H), 2.45 – 2.41 (m, 2H), 
1.77 – 1.73 (m, 2H).   
13C NMR: (126 MHz, CDCl3) δ 157.1, 157.1, 142.1, 140.3, 135.6, 133.9, 129.0, 127.9, 127.6, 
127.3, 124.0, 122.4, 54.1, 53.7, 25.4, 23.8, 23.8.   
HRMS: (ESI-TOF, m/z) calcd. For C19H18N3O2 [M+H]+ calc.: 320.1399; found: 320.1396.   
IR: (ATR, neat, cm-1) 2944 (w), 1763 (m), 1700 (s), 1480 (m), 1453 (m), 1393 (m), 1212 (w), 
1027 (w), 916 (w), 760 (m), 730 (m), 699 (m), 535 (w).   
m.p.: 234 – 235 ºC. 
 
 Synthesis of 31: Following the general procedure, the title compound was isolated 
by flash chromatography (SiO2, hexanes:EtOAc = 1:2) as a yellow solid (284.1 mg, 
88%).  
Rf = 0.39 (SiO2, hexanes:EtOAc = 1:4, UV, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 8.61 (d, J = 2.1 Hz, 1H), 7.77 (d, J = 2.1 Hz, 1H), 5.43 (t, J = 2.7 
Hz, 1H), 5.33 (t, J = 2.7 Hz, 1H), 2.88 (s, 3H), 2.52 – 2.35 (m, 2H), 1.85 – 1.74 (m, 1H), 1.75 – 
1.63 (m, 1H).   
13C NMR: (126 MHz, CDCl3) δ 156.8, 156.5, 153.0, 150.8, 133.9, 131.0, 121.0, 55.1, 52.9, 25.6, 
23.4, 22.7.   
HRMS: (ESI-TOF, m/z) calcd. For C12H11BrN4O2 [M]+ calc.: 322.0060; found: 322.0063.   
IR: (ATR, neat, cm-1) 2946 (w), 1765 (w), 1702 (s), 1448 (m), 1392 (m), 1214 (w), 986 (w), 764 
(w), 729 (w), 629 (w).   
 m.p.: 165– 166 ºC.  
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 Synthesis of 32: Following the general procedure, the title compound was isolated 
by flash chromatography (SiO2, hexanes:EtOAc = 2:1) as a white solid (150.9 mg, 
51%).  
Rf = 0.54 (SiO2, hexanes:EtOAc = 1:2, UV, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 8.15 (d, J = 8.2 Hz, 1H), 7.88 (d, J = 8.2 Hz, 1H), 7.85 (d, J = 8.2 
Hz, 1H), 7.62 (ddt, J = 8.2, 6.8, 1.1 Hz, 1H), 7.54 (ddt, J = 8.2, 6.8, 1.1 Hz, 1H), 7.43 (d, J = 8.2 
Hz, 1H), 6.09 (t, J = 2.7 Hz, 1H), 5.45 (t, J = 2.7 Hz, 1H), 2.77 (s, 3H), 2.59 – 2.42 (m, 2H), 1.79 
– 1.65 (m, 2H).   
13C NMR: (126 MHz, CDCl3) δ 157.5, 157.3, 133.4, 132.4, 131.0, 128.8, 128.7, 127.7, 127.4, 
126.3, 122.1, 121.5, 54.3, 49.4, 25.2, 23.7, 23.2.   
HRMS: (ESI-TOF, m/z) calcd. For C17H16N3O2 [M+H]+ calc.: 294.1243; found: 294.1242.   
IR: (ATR, neat, cm-1) 2943 (w), 2250 (w), 1767 (m), 1699 (s), 1451 (s), 1393 (s), 1207 (m), 1024 
(m), 914 (m), 819 (m), 765 (m), 728 (s), 595 (m).   
m.p.: 167 – 168 ºC. 
 
 Synthesis of 33: Following the general procedure, the title compound was isolated by 
flash chromatography (SiO2, hexanes:EtOAc = 1:4) as a white solid (250.9 mg, 92%).  
Rf = 0.10 (SiO2, n-hexane:EtOAc = 1:2, KMnO4) 
1H NMR (500 MHz, CDCl3) δ 8.58 (dd, J = 5.1, 1.6 Hz, 1H), 7.65 (dd, J = 7.6, 1.6 Hz, 1H), 7.34 
(dd, J = 7.6, 5.1 Hz, 1H), 5.50 (t, J = 2.8 Hz, 1H), 5.40 (t, J = 2.8 Hz, 1H), 2.91 (s, 3H), 2.55 – 
2.41 (m, 2H), 1.91 – 1.82 (m, 1H), 1.79 – 1.70 (m, 1H). 
13C NMR (126 MHz, CDCl3) δ 156.8, 156.5, 154.6, 149.7, 131.2, 129.8, 124.1, 55.6, 53.2, 25.4, 
23.5, 22.8. 
HRMS (EI-TOF, m/z) calcd. For C12H13N4O2 [M+H]+ calc.: 245.1033; found: 245.1039. 
IR (ATR, neat, cm-1): 2946 (w), 1769 (m), 1700 (s), 1581 (w), 1455 (s), 1394 (m), 1217 (m), 1029 
(w), 983 (w), 800 (w), 762 (m), 594 (w), 544 (w). 
MP: 158.8 - 159.6 °C 
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 Synthesis of 34: Following the general procedure, the title compound was isolated by 
flash chromatography (SiO2, hexanes:EtOAc = 1:4 to EtOAc) as a yellow solid (201.3 
mg, 82%).  
Rf = 0.14 (SiO2, hexanes:EtOAc = 1:4, UV, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 8.46 (s, 2H), 5.49 – 5.46 (m, 2H), 2.82 (s, 3H), 2.49 – 2.43 (m, 
2H), 1.81 – 1.75 (m, 2H).   
13C NMR: (126 MHz, CDCl3) δ 155.9, 149.7, 144.7, 54.8, 25.4, 22.8.   
HRMS: (ESI-TOF, m/z) calcd. For C11H11N5O2 [M]+ calc.: 245.0913; found: 245.0913.   
IR: (ATR, neat, cm-1) 2948 (w), 1764 (m), 1701 (s), 1454 (m), 1392 (m), 1233 (w), 1207 (w), 
1134 (m), 985 (m), 854 (w), 762 (m), 729 (m), 595 (m).   
m.p.: 172– 173 ºC.  
 
 
 Synthesis of 35: Following the general procedure, the title compound was 
isolated by flash chromatography (SiO2, hexanes:EtOAc = 1:2) as a brown solid 
(179.5 mg, 61%).  
Rf = 0.33 (SiO2, hexanes:EtOAc = 1:4, UV, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 8.13 (dt, J = 8.5, 0.9 Hz, 1H), 8.05 (s, 1H), 7.85 (dd, J = 8.1, 1.4 
Hz, 1H), 7.77 (ddd, J = 8.5, 6.9, 1.4 Hz, 1H), 7.60 (ddd, J = 8.1, 6.9, 0.9 Hz, 1H), 5.56 (t, J = 2.8 
Hz, 1H), 5.49 (t, J = 2.8 Hz, 1H), 2.85 (s, 3H), 2.62 – 2.47 (m, 2H), 2.02 – 1.93 (m, 1H), 1.87 – 
1.77 (m, 1H).   
13C NMR: (126 MHz, CDCl3) δ 156.7, 156.2, 155.0, 147.8, 130.6, 130.3, 129.8, 128.3, 128.2, 
127.7, 127.4, 56.0, 53.4, 25.5, 24.2, 23.1.   
HRMS: (ESI-TOF, m/z) calcd. For C16H15N4O2 [M+H]+ calc.: 295.1190; found: 295.1185.   
IR: (ATR, neat, cm-1) 2945 (w), 1699 (s), 1452 (m), 1392 (m), 1209 (w), 1025 (w), 861 (w), 762 
(m), 732 (m), 542 (m).   
m.p.: 183– 184 ºC. 
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 Synthesis of 36: Following the general procedure, the title compound was isolated 
by flash chromatography (SiO2, hexanes:EtOAc = 1:2) as a yellow solid (157.7 mg, 
54%).  
Rf = 0.33 (SiO2, hexanes:EtOAc = 1:4, UV, KMnO4).   
1H NMR: (500 MHz, CDCl3) δ 8.98 (dd, J = 4.2, 1.8 Hz, 1H), 8.15 (dd, J = 8.2, 1.8 Hz, 1H), 7.80 
(d, J = 8.2 Hz, 1H), 7.49 (d, J = 8.2 Hz, 1H), 7.42 (dd, J = 8.2, 4.2 Hz, 1H), 6.63 (t, J = 2.6 Hz, 
1H), 5.48 (t, J = 2.6 Hz, 1H), 2.75 (s, 3H), 2.54 – 2.42 (m, 2H), 1.76 – 1.67 (m, 2H).   
13C NMR: (126 MHz, CDCl3) δ 157.3, 156.9, 151.5, 142.4, 136.4, 135.9, 132.9, 128.4, 128.1, 
122.2, 121.7, 53.9, 48.4, 25.3, 23.8, 23.0.   
HRMS: (ESI-TOF, m/z) calcd. For C16H14KN4O2 [M+K]+ calc.: 333.0748; found: 333.0764.   
IR: (ATR, neat, cm-1) 2942 (w), 1764 (m), 1698 (s), 1451 (s), 1393 (m), 1209 (m), 1158 (w), 1024 
(w), 840 (m), 764 (m).   
 m.p.: 220– 221 ºC. 
 
 
Cycloreversion of MTAD cycloadducts 
 
 
 
Cycloadduct (0.4 mmol, 1.0 eq.) and potassium hydroxide (248.9 mg, 90% w/w, 4.0 mmol, 10.0 
eq.) in 2-propanol (2.0 mL, 0.2 M) were stirred at 100 ºC under a nitrogen atmosphere until full 
conversion of 3 was observed by TLC analysis. Reaction was then cooled to 0 ºC, and acetic acid 
0.23 mL (4.0 mmol, 10.0 eq.) was added dropwise to neutralize to pH 6. Volatiles were then 
removed in vacuo, and the resulting residue was dissolved in distilled water (1.0 mL). An aqueous 
solution of CuCl2 (1.0 M, 0.4 mL, 1.0 eq.) was added, and the mixture was stirred for one minute. 
Aqueous ammonium hydroxide (5.0 M, 1.5 mL) was then added to the resulting brown solution, 
and the color of the solution turned dark blue. After adding ethyl acetate (5 mL), the mixture was 
transferred to a separatory funnel. The organic layer was separated, and the aqueous layer was 
extracted with ethyl acetate (3 × 5 mL). The combined organic layers were washed with saturated 
aqueous sodium chloride solution (10 mL), dried over magnesium sulfate, and concentrated in 
vacuo. For most of the cases, the desired cyclohexadiene was obtained in analytically pure form 
without further purification. Otherwise, the crude mixture was purified by flash chromatography 
(SiO2, n-hexane:EtOAc mixtures).  
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Synthesis of 37: Following the general procedure, the title compound was synthesized 
and confirmed by NMR analysis (yellow oil, 53% yield based on 1H NMR analysis 
using 1,3,5-trimethoxybenzene as an internal standard).   
1H NMR: (500 MHz, CDCl3) δ 5.85 – 5.70 (m, 2H), 5.50 – 5.35 (m, 1H), 2.11 – 2.04 (m, 4H), 
1.71 (s, 3H).   
13C NMR: (126 MHz, CDCl3) δ 131.6, 128.3, 126.6, 120.6, 31.7, 22.8, 22.6.   
The analytical data was in accordance with previously reported values.36 
  
 Synthesis of 38: Following the general procedure, the title compound was synthesized 
and confirmed by NMR analysis (yellow oil, 90% yield based on 1H NMR analysis 
using MeNO2 as an internal standard).  
Rf = 0.77 (SiO2, hexanes:EtOAc = 10:1, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 6.07 (dd, J = 9.7, 1.9 Hz, 1H), 5.86 (dtd, J = 9.7, 4.5, 0.9 Hz, 1H), 
5.54 (tdd, J = 4.5, 1.9, 0.9 Hz, 1H), 2.14 – 2.07 (m, 2H), 2.06 – 1.98 (m, 2H), 1.04 (s, 9H).   
13C NMR: (126 MHz, CDCl3) δ 144.1, 126.6, 125.2, 116.5, 34.0, 29.0, 22.7, 22.4.   
HRMS: (ESI-TOF, m/z) calcd. For C10H16Na [M+Na]+ calc.: 159.1144; found: 159.1147.  
IR: (ATR, neat, cm-1) 2955 (w), 2924 (w), 2856 (w), 1717 (w), 1462 (w). 
  
Synthesis of 39: Following the general procedure, the title compound was isolated as 
a colorless oil (48.3 mg, 79%).  
Rf = 0.87 (SiO2, hexanes:EtOAc = 10:1, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 6.10 (tt, J = 4.3, 1.2 Hz, 1H), 6.01 (ddt, J = 9.6, 1.9, 1.2 Hz, 1H), 
5.81 (ddt, J = 9.6, 4.3, 1.2 Hz, 1H), 2.18 – 2.01 (m, 4H), 0.07 (s, 9H).   
13C NMR: (126 MHz, CDCl3) δ 136.1, 135.1, 126.4, 125.4, 23.3, 22.0, –1.8.   
HRMS: (ESI-TOF, m/z) calcd. For C9H16Si [M]+ calc.: 152.1016; found: 152.1014.   
IR: (ATR, neat, cm-1) 2953 (m), 2925 (m), 2859 (w), 1710 (w), 1679 (w), 1455 (w), 1248 (m), 
838 (s), 753 (w).   
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Synthesis of 40: Following the general procedure, the title compound was isolated as 
a colorless oil (55.3 mg, 91%).  
Rf = 0.87 (SiO2, hexanes:EtOAc = 10:1, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 5.84 – 5.70 (m, 3H), 5.60 (ddt, J = 7.5, 5.1, 3.9, 1.1 Hz, 1H), 2.48 
(dddd, J = 17.0, 10.2, 3.9, 2.1 Hz, 1H), 2.18 (dddd, J = 17.0, 7.8, 5.1, 1.6 Hz, 1H), 1.64 (dddd, J 
= 10.2, 7.8, 4.8, 1.6 Hz, 1H), 0.02 (s, 9H).   
13C NMR: (126 MHz, CDCl3) δ 129.1, 124.7, 124.5, 122.3, 24.0, 23.2, –2.7.   
 HRMS: (ESI-TOF, m/z) calcd. For C9H16Si [M]+ calc.: 152.1016; found: 152.1018.   
IR: (ATR, neat, cm-1) 2953 (m), 2923 (m), 1679 (m), 1541 (m), 1462 (m), 1413 (w), 1248 (s), 
1104 (w), 836 (s), 752 (m).   
  
Synthesis of 41: Following the general procedure, the title compound was isolated 
by flash chromatography (SiO2, hexanes:EtOAc = 4:1) as a colorless oil (42.3 mg, 
85%).  
Synthesis of 41 on large scale: Following the general procedure using compound 14 (881.0 mg, 
3.15 mmol, 1.0 eq.), the title compound was isolated by flash chromatography (SiO2, 
hexanes:EtOAc = 4:1) as a colorless oil (300.0 mg, 77%).  
Rf = 0.30 (SiO2, hexanes:EtOAc = 2:1, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 5.92 – 5.85 (m, 1H), 5.83 (dd, J = 9.7, 1.5 Hz, 1H), 5.60 (tt, J = 
4.0, 1.5 Hz, 1H), 3.67 (t, J = 6.2 Hz, 2H), 2.29 (td, J = 6.2, 1.4 Hz, 2H), 2.20 – 2.07 (m, 4H), 1.41 
(br, 1H).   
13C NMR: (126 MHz, CDCl3) δ 133.1, 128.0, 126.7, 123.4, 61.2, 39.1, 22.6, 22.5.   
HRMS: (ESI-TOF, m/z) calcd. For C8H12O [M]+ calc.: 124.0883; found: 124.0880.   
IR: (ATR, neat, cm-1): 3338 (br, m), 3033 (w), 2931 (m), 2873 (m), 2822 (m), 1426 (w), 1359 (w), 
1046 (s), 736 (m), 589 (m).   
  
  
Synthesis of 42: Compound 12 (100.0 mg, 0.27 mmol, 1.0 eq.) was refluxed in 
anhydrous hydrazine (0.17 mL, 5.5 mmol, 20 eq.) at 100 ºC for 20 h. Volatiles 
were removed in vacuo, and the residue was taken up in THF:H2O (2:1, 1.5 mL). 
Sodium bicarbonate (114.6 mg, 1.36 mmol, 5.0 eq.) and di-tert-butyl dicarbonate (119.1 mg, 0.55 
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mmol, 2.0 eq.) were added, and the reaction mixture was stirred at 50 ºC for 2 h. CuCl2 (0.8 mL, 
1.0 M in H2O, 3.0 eq.) was then added at rt, and the mixture was further stirred for one minute. 
After adding ethyl acetate (5.0 mL), the mixture was transferred to a separatory funnel. The organic 
layer was separated, and the aqueous later extracted with ethyl acetate (3 × 5.0 mL). The combined 
organic layers were washed with saturated aqueous sodium chloride solution (10 mL), dried over 
magnesium sulfate, and concentrated in vacuo. The crude mixture was purified by flash 
chromatography (SiO2, hexanes:EtOAc mixtures) to provide the desired compound 42 as a 
colorless oil (42.0 mg, 69%).  
Rf = 0.42 (SiO2, hexanes:EtOAc = 10:1, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 5.90 – 5.76 (m, 2H), 5.53 (ddt, J = 5.4, 3.7, 1.4 Hz, 1H), 4.52 (s, 
1H), 3.21 – 3.17 (m, 2H), 2.20 – 2.17 (m, 2H), 2.13 – 2.09 (m, 4H), 1.44 (s, 9H).  
13C NMR: (126 MHz, CDCl3) δ 156.2, 133.1, 127.8, 126.8, 122.7, 79.2, 39.5, 36.2, 28.8, 22.45, 
22.41.   
HRMS: (ESI-TOF, m/z) calcd. For C13H21NO2 [M]+ calc.: 223.1572; found: 223.1568.   
IR: (ATR, neat, cm-1) 3355 (w), 2976 (w), 2930 (w), 2873 (w), 1690 (s), 1505 (m), 1365 (m), 1249 
(m), 1166 (s), 736 (w).   
  
 Synthesis of 43: Following the general procedure, the title compound was isolated 
as a colorless oil (36.9 mg, 84%).   
Rf = 0.42 (SiO2, hexanes:EtOAc = 2:1, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 6.00 (dd, J = 9.8, 1.6 Hz, 1H), 5.97 – 5.88 (m, 1H), 5.77 (tt, J = 
3.9, 1.6 Hz, 1H), 4.12 (d, J = 1.6 Hz, 2H), 2.27 – 2.14 (m, 4H), 1.42 (s, 1H).   
13C NMR: (126 MHz, CDCl3) δ 135.7, 127.8, 124.6, 122.3, 65.8, 22.4, 22.2.   
HRMS: (ESI-TOF, m/z) calcd. For C7H11O [M+H]+ calc.: 111.0804; found: 111.0809.   
IR: (ATR, neat, cm-1) 3324 (br, m), 2930 (m), 2871 (m), 2823 (m), 1426 (m), 1014 (s), 995 (s), 
820 (m), 725 (s), 663 (s).   
  
Synthesis of 44: Following the general procedure, the title compound was isolated 
as a yellow oil (47.2 mg, 95%).  
Rf = 0.42 (SiO2, hexanes:EtOAc = 2:1, KMnO4).  
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1H NMR: (500 MHz, CDCl3) δ 5.99 (dt, J = 9.9, 1.5 Hz, 1H), 5.88 (dtd, J = 9.9, 3.6, 1.5 Hz, 1H), 
5.68 (dtd, J = 5.0, 3.6, 1.5 Hz, 1H), 4.25 (q, J = 6.4 Hz, 1H), 2.18 – 2.07 (m, 4H), 1.78 (br, 1H), 
1.26 (d, J = 6.4 Hz, 3H).   
13C NMR: (126 MHz, CDCl3) δ 139.7, 127.7, 123.5, 120.1, 70.3, 22.5, 22.2, 22.1.   
HRMS: (ESI-TOF, m/z) calcd. For C8H12O [M]+ calc.: 124.0888; found: 124.0888.   
IR: (ATR, neat, cm-1) 3339 (br), 2971 (m), 2872 (m), 2872 (m), 2823 (m), 1426 (m), 1066 (s), 945 
(m), 819 (m), 598 (s).   
  
Synthesis of 45: The reaction was conducted following the general procedure, 
except the neutralization after the hydrolysis of urazole moiety was not conducted. 
The title compound was isolated by flash chromatography (SiO2, hexanes:EtOAc = 
20:1) as a colorless oil (44.1 mg, 71%).  
Rf = 0.27 (SiO2, hexanes:EtOAc = 10:1, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 5.98 (d, J = 9.8 Hz, 1H), 5.93 – 5.89 (m, 1H), 5.88 – 5.86 (m, 1H), 
4.65 (s, 1H), 3.30 (s, 6H), 2.25 – 2.18 (m, 2H), 2.19 – 2.10 (m, 2H).   
13C NMR: (126 MHz, CDCl3) δ 133.2, 127.6, 124.7, 122.9, 104.4, 53.3, 22.3, 22.0.   
HRMS: (ESI-TOF, m/z) calcd. For C9H15O2 [M+H]+ calc.: 155.1067; found: 155.1064.   
IR: (ATR, neat, cm-1) 2933 (w), 2825 (w), 1367 (w), 1193 (w), 1098 (m), 1075 (m), 1051 (s), 1000 
(w), 945 (w), 813 (w).   
  
Synthesis of 46: The reaction was conducted following the general procedure, 
except the neutralization after the hydrolysis of urazole moiety was not conducted. 
The title compound was isolated as a colorless oil (63.2 mg, 94%).  
Rf = 0.47 (SiO2, hexanes:EtOAc = 10:1, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 5.99 – 5.92 (m, 2H), 5.86 (ddt, J = 9.5, 5.0, 2.5 Hz, 1H), 3.14 (s, 
6H), 2.25 – 2.13 (m, 2H), 2.13 – 2.02 (m, 2H), 1.33 (s, 3H).   
13C NMR: (126 MHz, CDCl3) δ 136.8, 127.1, 123.7, 123.1, 100.8, 48.8, 23.1, 22.2, 22.1.   
HRMS: (ESI-TOF, m/z) calcd. For C10H16O2 [M+Na]+ calc.: 191.1043; found: 191.1036.   
IR: (ATR, neat, cm-1) 2937 (w), 2827 (w), 1272 (m), 1190 (m), 1142 (s), 1066 (s), 1051 (s), 1031 
(s), 872 (s), 629 (m).   
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Synthesis of 47: The reaction was conducted following the general procedure, 
except the neutralization after the hydrolysis of urazole moiety was not conducted. 
The title compound was isolated by flash chromatography (SiO2, hexanes:EtOAc = 
20:1) as a colorless oil (65.3 mg, 89%).  
Rf = 0.31 (SiO2, hexanes:EtOAc = 10:1, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 6.13 (tt, J = 4.3, 1.5 Hz, 1H), 5.96 (dt, J = 9.8, 1.5 Hz, 1H), 5.87 
(dtd, J = 9.8, 4.3, 1.0 Hz, 1H), 3.13 (s, 9H), 2.25 – 2.20 (m, 2H), 2.17 – 2.07 (m, 2H).   
13C NMR: (126 MHz, CDCl3) δ 131.3, 127.3, 127.3, 123.1, 114.2, 49.5, 22.1, 22.0.   
HRMS: (ESI-TOF, m/z) calcd. For C10H20NO3 [M+NH4]+ calc.: 202.1438; found: 202.1433.   
IR: (ATR, neat, cm-1) 2942 (w), 2823 (w), 1437 (w), 1270 (m), 1183 (w), 1088 (s), 1061 (s), 1038 
(m), 833 (w), 748 (w).   
 
Synthesis of 48: Following the general procedure, the title compound was isolated 
by flash chromatography (SiO2, hexanes:EtOAc = 20:1) as a colorless oil (35.6 mg, 
58%).  
Rf = 0.49 (SiO2, hexanes:EtOAc = 10:1, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 5.94 (ddd, J = 8.2, 1.5 Hz, 1H), 5.89 – 5.83 (m, 1H), 5.71 (ddt, J 
= 4.2, 2.8, 1.5 Hz, 1H), 3.90 (d, J = 1.5 Hz, 2H), 3.59 (sept, J = 6.1 Hz, 1H), 2.25 – 2.05 (m, 4H), 
1.15 (d, J = 6.1 Hz, 6H).   
13C NMR: (126 MHz, CDCl3) δ 133.6, 127.2, 125.2, 123.0, 72.2, 70.6, 22.4, 22.3, 22.2.   
HRMS: (ESI-TOF, m/z) calcd. For C10H16O [M]+ calc.: 152.1196; found: 152.1197.   
IR: (ATR, neat, cm-1) 3039 (w), 2917 (s), 2875 (m), 2859 (m), 1356 (w), 1240 (w), 1095 (m), 
1066 (m), 821 (w), 734 (w).   
  
Synthesis of 49: Following the general procedure using 20 (99.7 mg, 0.34 mmol, 
1.0 eq.), the title compound was isolated by flash chromatography (SiO2, 
hexanes:EtOAc = 6:1) as a colorless oil (55.1 mg, 97%).  
Rf = 0.47 (SiO2, hexanes:EtOAc = 2:1, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 11.33 (br, 1H), 5.93 (d, J = 9.8 Hz, 1H), 5.87 (dt, J = 9.8, 4.2 Hz, 
1H), 5.70 (t, J = 4.2 Hz, 1H), 2.26 – 2.19 (m, 2H), 2.17 – 2.09 (m, 2H), 1.34 (s, 6 H).   
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13C NMR: (126 MHz, CDCl3) δ 185.3 (detected from HMBC), 138.2, 127.5, 124.6, 119.8, 47.6 
(detected from HMBC), 24.5, 22.6, 22.0.   
HRMS: (ESI-TOF, m/z) calcd. For C10H14O2 [M]+ calc.: 166.0994; found: 166.0991.  
IR: (ATR, neat, cm-1) 3039 (w), 2917 (s), 2875 (m), 2859 (m), 1356 (w), 1240 (w), 1095 (m), 
1066 (m), 821 (w), 734 (w).   
  
Synthesis of 50: Following the general procedure, the title compound was isolated as 
a colorless oil (54.4 mg, 90%).  
Rf = 0.70 (SiO2, hexanes:EtOAc = 10:1, KMnO4).  
1H NMR: (500 MHz, CDCl3) δ 5.98 (dd, J = 9.7, 2.1 Hz, 1H), 5.90 (dt, J = 9.7, 4.2 Hz, 1H), 5.65 
(t, J = 4.5 Hz, 1H), 3.44 (s, 2H), 2.19 – 2.11 (m, 2H), 2.10 – 2.02 (m, 2H), 1.14 (s, 6H).   
13C NMR: (126 MHz, CDCl3) δ 139.5, 127.6, 123.9, 120.4, 54.6, 39.2, 24.6, 22.7, 22.1.   
HRMS: (ESI-TOF, m/z) calcd. For C10H15Cl [M]+ calc.: 170.0862; found: 170.0861.   
IR: (ATR, neat, cm-1) 3042 (w), 2974 (w), 2933 (w), 2875 (w), 2829 (w), 1466 (w), 1366 (w), 
1281 (w), 1061 (w), 814 (w), 746 (w), 711 (m), 600 (m).   
  
Synthesis of 51: Following the general procedure, the title compound was isolated 
by flash chromatography (SiO2, hexanes:EtOAc = 1:1) as an off-white oil (48.8 mg, 
61%).   
1H NMR: (500 MHz, CDCl3) δ 11.55 (br, 1H), 7.90 (dd, J = 7.7, 1.4 Hz, 1H), 7.49 
(td, J = 7.7, 1.4 Hz, 1H), 7.34 (td, J = 7.7, 1.4 Hz, 1H), 7.29 (dd, J = 7.7, 1.4 Hz, 1H), 5.95 (dd, J 
= 9.7, 1.7 Hz, 1H), 5.92 – 5.84 (m, 1H), 5.83 – 5.76 (m, 1H), 2.32 (m, 2H), 2.22 (m, 2H).  
13C NMR: (126 MHz, CDCl3) δ 172.7, 143.7, 137.4, 132.8, 130.6, 130.0, 130.1, 127.3, 127.0, 
126.1, 124.0, 23.6, 22.9.   
The analytical data was in accordance with previously reported values.37 
 
 
N,N-bond fragmentation of polynuclear cycloadducts 
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A mixture of cycloadduct (0.2 mmol, 1.0 equiv.) and anhydrous hydrazine (0.125 mL, 4.0 mmol, 
20 equiv.) was stirred at 100 °C until full conversion of the cycloadduct was observed. The reaction 
was then cooled to 50 °C, and ethanol (1 mL) was added under an atmosphere of H2 (balloon). 
Raney®-Nickel (0.1 mL, W.R. Grace and Co. Raney® 2400, slurry, in H2O) was added, and the 
resulting mixture was stirred under a hydrogen atmosphere at 50 °C for 8 h, then filtered through 
a plug of Celite. The product was purified by column chromatography (SiO2, 5% NH4OH (5.0 M, 
aq) in MeOH) to provide compound diamine. 
 
Synthesis of 52: Following the general procedure, the title compound was isolated by 
flash chromatography (SiO2, 5% NH4OH (5 M, aq) in MeOH) as a brown oil (25.0 
mg, 77%).  
Rf = 0.26 (SiO, 5% NH4OH (5 M, aq) in MeOH, ninhydrin).  
1H NMR: (500 MHz, CDCl3) δ 7.40 (dd, J = 5.7, 3.4 Hz, 2H), 7.24 (dd, J = 5.7, 3.4 Hz, 2H), 3.94 
(t, J = 5.5 Hz, 2H), 2.03 – 1.97 (m, 2H), 1.91 (br, 4H), 1.85 – 1.78 (m, 2H).   
 13C NMR: (126 MHz, CDCl3) δ 140.9, 127.9, 127.4, 49.8, 30.2.   
HRMS: (ESI-TOF, m/z) calcd. For C10H14KN2 [M+K]+ calc.: 201.0789; found: 201.0785.   
IR: (ATR, neat, cm-1) 3277 (br, m), 2928 (m), 1571 (s), 1449 (s), 1370 (m), 1350 (m), 940 (w), 
771 (m), 722 (w). 
 
Synthesis of 53: Following the general procedure, the title compound was isolated 
by flash chromatography (SiO2, 5% NH4OH (5 M, aq) in MeOH) as a brown oil 
(29.4 mg, 59%).  
Rf = 0.10 (SiO2, 5% NH4OH (5 M, aq) in MeOH, ninhydrin).  
1H NMR: (500 MHz, CDCl3) δ 7.41 – 7.33 (m, 2H), 7.21 (t, J = 7.7 Hz, 1H), 4.46 
(d, J = 3.2 Hz, 1H), 4.00 (t, J = 7.5 Hz, 1H), 3.35 (s, 3H), 3.15 (s, 3H), 2.10 – 2.08 (m, 5H), 2.06 
– 1.97 (m, 1H), 1.95 – 1.85 (m, 1H), 1.80 – 1.70 (m, 1H), 1.54 (s, 3H).   
 13C NMR: (126 MHz, CDCl3) δ 142.3, 141.1, 140.2, 128.8, 127.1, 126.5, 104.1, 51.0, 49.7, 48.7, 
46.1, 30.1, 27.8, 26.0.   
HRMS: (ESI-TOF, m/z) calcd. For C14H22N2NaO2 [M+Na]+ calc.: 273.1573; found: 273.1562.   
IR: (ATR, neat, cm-1) 3360 (br, w), 2933 (m), 1580 (m), 1460 (m), 1371 (m), 1265 (m), 1143 (s), 
1088 (s), 870 (m), 759 (m).   
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Synthesis of 54: Following the general procedure E, the title compound was 
isolated by flash chromatography (SiO2, 5% NH4OH (5 M, aq) in MeOH) as a 
brown oil (30.4 mg, 65%).  
Rf = 0.26 (SiO2, 5% NH4OH (5 M, aq) in MeOH, ninhydrin).  
1H NMR: (500 MHz, CDCl3) δ 7.66 (d, J = 1.8 Hz, 1H), 7.62 – 7.57 (m, 2H), 7.53 – 7.46 (m, 2H), 
7.43 (t, J = 7.6 Hz, 2H), 7.34 (t, J = 7.4 Hz, 1H), 4.08 – 3.88 (m, 2H), 2.10 – 2.00 (m, 2H), 1.92 – 
1.82 (m, 2H), 1.70 (br, 4H).   
13C NMR: (126 MHz, CDCl3) δ 141.2, 141.1, 140.3, 139.9, 128.9, 128.4, 127.4, 127.2, 126.6, 
126.1, 49.8, 49.5, 30.3, 30.2.   
HRMS: (ESI-TOF, m/z) calcd. For C16H19N2 [M+H]+ calc.: 239.1543; found: 239.1533.   
IR: (ATR, neat, cm-1) 3353 (w), 2924 (m), 2885 (m), 1599 (m), 1482 (s), 904 (m), 830 (s), 766 
(s), 756 (s), 698 (s).   
 
 
Synthesis of 55: Following the general procedure, the title compound was isolated 
by flash chromatography (SiO2, 5% NH4OH (5 M, aq) in MeOH) as a brown oil 
(26.0 mg, 54%).  
Rf = 0.03 (SiO2, 5% NH4OH (5 M, aq) in MeOH, ninhydrin).  
1H NMR: (500 MHz, CDCl3) δ 8.51 (d, J = 2.2 Hz, 1H), 7.94 (d, J = 2.2 Hz, 1H), 4.03 – 3.73 (m, 
2H), 2.10 (dddd, J = 14.2, 9.0, 5.8, 3.3 Hz, 1H), 2.05 – 1.97 (m, 1H), 1.92 – 1.86 (m, 1H), 1.86 – 
1.78 (m, 1H), 1.69 (br, 4H).   
13C NMR: (126 MHz, CDCl3) δ 157.8, 149.2, 138.7, 137.5, 119.1, 51.0, 49.5, 30.2, 27.7.   
HRMS: (ESI-TOF, m/z) calcd. For C9H12BrN3 [M]+ calc.: 241.0209; found: 241.0212.   
IR: (ATR, neat, cm-1) 3349 (w), 2934 (m), 2856 (m), 1685 (m), 1588 (m), 1437 (s), 899 (s), 858 
(m), 781 (m), 625 (w).  
 
 
56 
 
Synthesis of 56: Following the general procedure, the title compound was isolated 
by flash chromatography (SiO2, 5% NH4OH (5 M, aq) in MeOH) as a brown oil 
(41.4 mg, 97%).  
Rf = 0.26 (SiO2, 5% NH4OH (5 M, aq) in MeOH, ninhydrin).  
1H NMR: (500 MHz, CDCl3) δ 8.19 (d, J = 8.6 Hz, 1H), 7.81 (dd, J = 8.1, 1.4 Hz, 1H), 7.75 (d, 
J = 8.6 Hz, 1H), 7.68 (d, J = 8.6 Hz, 1H), 7.54 (ddd, J = 8.6, 6.8, 1.4 Hz, 1H), 7.46 (dd, J = 8.1, 
6.8 Hz, 1H), 4.74 (t, J = 3.2 Hz, 1H), 4.04 (dd, J = 10.2, 5.9 Hz, 1H), 2.17 – 2.09 (m, 1H), 2.09 – 
2.02 (m, 2H), 2.00 – 1.90 (m, 1H), 1.85 (br s, 4H).   
13C NMR: (126 MHz, CDCl3) δ 138.1, 134.9, 133.0, 131.7, 128.8, 127.9, 126.7, 125.4, 125.3, 
123.7, 50.9, 45.0, 31.0, 29.0.   
HRMS: (ESI-TOF, m/z) calcd. For C14H20N3 [M+NH4]+ calc.: 230.1652; found: 230.1661.   
IR: (ATR, neat, cm-1) 3276 (br, w), 2924 (m), 2856 (m), 1597 (m), 1507 (m), 1198 (w), 906 (m), 
817 (s), 751 (s), 732 (s).   
 
 
 Synthesis of 57: Following the general procedure, the title compound was isolated by 
flash chromatography (SiO2, 5% NH4OH (5 M, aq) in MeOH) as a brown oil (34.0 
mg, 92%).  
Rf = 0.09 (SiO2, 5% NH4OH (5 M, aq) in MeOH, ninhydrin).  
1H NMR (500 MHz, CDCl3) δ 8.47 (dd, J = 4.8, 1.7 Hz, 1H), 7.74 (dd, J = 7.8, 1.7 Hz, 1H), 7.16 
(dd, J = 7.8, 4.7 Hz, 1H), 4.02 – 3.94 (m, 2H), 2.11 (dddd, J = 13.2, 8.4, 5.3, 3.3 Hz, 1H), 2.03 
(dddd, J = 13.2, 9.9, 5.3, 3.3 Hz, 1H), 1.95 – 1.85 (m, 1H), 1.84 (tdd, J = 8.4, 5.3, 2.6 Hz, 1H), 
1.77 (br s, 4H). 
13C NMR (126 MHz, CDCl3) δ 159.3, 148.3, 136.4, 135.5, 122.4, 51.5, 49.5, 30.3, 27.7. 
IR (ATR, neat, cm-1): 3349 (m), 3275 (m), 2927 (m), 2857 (w), 1574 (s), 1437 (s), 1372 (m), 942 
(m), 808 (m), 728 (m). 
HRMS (EI-TOF, m/z) calcd. For C9H17N4 [M+NH4]+ calc.: 181.1448; found: 181.1445. 
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Synthesis of 58: Following the general procedure, the title compound was isolated by 
flash chromatography (SiO2, 5% NH4OH (5 M, aq) in MeOH) as a brown oil (17.4 
mg, 53%).  
Rf = 0.12 (SiO2, 5% NH4OH (5 M, aq) in MeOH, ninhydrin).  
1H NMR: (500 MHz, CDCl3) δ 8.44 (s, 2H), 4.13 – 4.01 (m, 2H), 2.19 – 2.09 (m, 2H), 1.99 – 1.91 
(m, 2H), 1.84 (br, 4H).   
13C NMR: (126 MHz, CDCl3) δ 154.7, 143.1, 51.3, 27.7   
HRMS: (ESI-TOF, m/z) calcd. For C8H12N4Na [M+Na]+ calc.: 187.0954; found: 187.0954.   
IR: (ATR, neat, cm-1) 3352(s), 3284 (s), 2944 (w), 1594 (m), 1407 (m), 1375 (w), 1151 (w), 1069 
(w), 947 (m), 629 (w). 
 
Synthesis of 59: Following the general procedure, the title compound was isolated 
by flash chromatography (SiO2, 5% NH4OH (5 M, aq) in MeOH) as a brown oil 
(31.8 mg, 75%).  
Rf = 0.41 (SiO2, 5% NH4OH (5 M, aq) in MeOH, ninhydrin).  
1H NMR: (500 MHz, CDCl3) δ 8.20 (s, 1H), 8.02 (d, J = 8.4 Hz, 1H), 7.78 (dd, J = 8.1, 1.4 Hz, 
1H), 7.66 (ddd, J = 8.4, 6.8, 1.4 Hz, 1H), 7.48 (dd, J = 8.1, 6.8 Hz, 1H), 4.21 – 4.16 (m, 1H), 4.13 
(dd, J = 8.0, 5.7 Hz, 1H), 2.23 (dddd, J = 13.3, 7.5, 5.7, 4.0 Hz, 1H), 2.13 (ddd, J = 13.3, 9.1, 4.0 
Hz, 1H), 1.98 (br, 4H), 1.97 – 1.85 (m, 2H).   
13C NMR: (126 MHz, CDCl3) δ 160.7, 147.2, 134.9, 134.2, 129.3, 128.7, 127.7, 127.5, 126.3, 
52.0, 49.7, 30.4, 27.9.   
HRMS: (ESI-TOF, m/z) calcd. For C13H15N3Na [M+Na]+ calc.: 236.1158; found: 236.1164.   
IR: (ATR, neat, cm-1) 3350 (m), 2937 (w), 1597 (m), 1491 (m), 1446 (w), 1374 (w), 918 (m), 793 
(m), 760 (s), 480 (w). 
 
Synthesis of 60: Following the general procedure, the title compound was isolated 
by flash chromatography (SiO2, 5% NH4OH (5 M, aq) in MeOH) as a brown oil 
(24.8 mg, 58%).  
Rf = 0.20 (SiO2, 5% NH4OH (5 M, aq) in MeOH, ninhydrin).  
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1H NMR: (500 MHz, CDCl3) δ 8.91 (dd, J = 4.2, 1.8 Hz, 1H), 8.11 (dd, J = 8.2, 1.8 Hz, 1H), 7.75 
(d, J = 8.6 Hz, 1H), 7.70 (d, J = 8.6 Hz, 1H), 7.38 (dd, J = 8.2, 4.2 Hz, 1H), 4.98 (t, J = 4.3 Hz, 
1H), 4.06 (dd, J = 9.2, 4.7 Hz, 1H), 2.15 – 2.06 (m, 3H), 2.01 – 1.95 (m, 1H), 1.94 (br, 4H).   
 13C NMR: (126 MHz, CDCl3) δ 149.6, 147.1, 141.7, 137.5, 136.4, 127.4, 126.8, 126.6, 120.8, 
51.0, 45.2, 30.1, 29.4.   
HRMS: (ESI-TOF, m/z) calcd. For C13H15N3 [M]+ calc.: 213.1260; found: 213.1251.   
IR: (ATR, neat, cm-1) 3347 (w), 2927 (m), 2857 (w), 1595 (m), 1498 (m), 1455 (m), 1370 (w), 
942 (w), 838 (s), 812 (s).   
 
 
 
 
 
 
Compound 28 (50.0 mg, 0.21 mmol, 1.0 eq) and anhydrous hydrazine (0.125 mL, 4.11 mmol, 20.0 
eq) under a nitrogen atmosphere was heated at 100 ºC for 8 h. Reaction was then cooled to rt, and 
hydrazine was removed at 50 ºC in vacuo. Dichloromethane (10 mL) was added to dissolve the 
residue, and oxygen gas was bubble through the reaction at rt for 15 minutes. After stirring the 
mixture under oxygen atmosphere for 4 h, 1,8-diazabicyclo[5.4.0]undec-7-ene (92 µL, 0.62 mmol, 
3.0 eq) was added, and the reaction was further stirred for 45 minutes. The reaction was quenched 
with aqueous saturated ammonium chloride solution (5 mL) and extracted with ethyl acetate (3 x 
5 mL). The combined organic layers were washed with saturated aqueous sodium chloride solution 
(10 mL), dried over magnesium sulfate, and concentrated in vacuo. The crude mixture was purified 
by column chromatography (SiO2, n-hexane/EtOAc = 1:1) to afford the titled compound 63 as a 
brown oil (20.1 mg, 60%).  
 
1H NMR: (500 MHz, CDCl3) δ 8.04 – 7.97 (m, 1H), 7.64 – 7.55 (m, 2H), 7.41 (ddd, J = 8.1, 5.1, 
3.4 Hz, 1H), 4.98 (dd, J = 7.8, 3.9 Hz, 1H), 2.93 (ddd, J = 17.4, 7.8, 4.5 Hz, 1H), 2.59 (ddd, J = 
17.4, 9.6, 4.5 Hz, 1H), 2.40 (ddt, J = 13.0, 7.8, 4.5 Hz, 1H), 2.35 (br, 1H), 2.18 (dddd, J = 13.0, 
9.6, 7.8, 4.5 Hz, 1H).  
 13C NMR: (126 MHz, CDCl3) δ 197.7, 145.5, 134.2, 131.2, 128.5, 127.3, 127.2, 68.0, 35.3, 
32.2.  
The analytical data was in accordance with previously reported values.38 
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1H and 13C NMR Spectra 
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